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 The intestinal epithelium regenerates every 5-7 days, a process that is facilitated 
by a pool of intestinal stem cells. Over the past decade, it has become apparent that the 
intestinal stem cell pool is diverse, containing at least two populations. Active stem cells 
(aISCs) are moderately proliferative and contribute to homeostatic regeneration, while 
reserve stem cells (rISCs) are slowly proliferative and facilitate regeneration following 
damage-induced loss of the aISC population. The genetic mechanisms required for the 
production and maintenance of rISCs are unknown. Sox9 is a transcription factor that 
has been shown to maintain stem cell populations in various tissues. In the intestinal 
epithelium, Sox9 is expressed in a gradient that negatively correlates with proliferative 
capacity. Transit-amplifying progenitors express the lowest levels of Sox9, while aISCs 
express intermediate levels, and cells expressing the highest levels of Sox9 are 
consistent with slowly cycling rISCs. In this dissertation, I will address the role that Sox9 
plays in maintaining rISC function within the intestinal epithelium.  I find that Sox9 is not 
only necessary for the production of a quiescent rISCs, but that it is also uniformly 
necessary for maintaining radioresistance within the rISC pool. This work identifies 
Sox9 as a novel intrinsic regulator of the rISC state. 
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CHAPTER 1: INTRODUCTION 
 
The anatomy and physiology of the small intestine 
The small intestine 
The gastrointestinal tract (GI tract) is a multi-organ system that is responsible for 
the digestion of foodstuffs, uptake of nutrients, and expulsion of resultant waste 
products.1 The digestive process involves mechanical and chemical breakdown of 
complex foods into simple nutrients that can be absorbed and utilized at the cellular 
level.1,2 The GI tract harbors hundreds of thousands of microorganisms, collectively 
known as the intestinal microbiota, a subset of which symbiotically aid in food 
digestion.1,2 Importantly, the GI tract coordinates with other organ systems to regulate 
the digestive process by secreting hormones that play a role in controlling appetite, 
glucose and lipid metabolism, and mucosal immunity.1,2 Although all organs of the GI 
tract are integral to digestion, the small intestine, which is the predominant site of 
nutrient absorption, is the focus of this work.2  
The small intestine is a tube-shaped organ that is composed of four tissue layers 
organized in a concentric manner: the serosa, the muscularis propria, the submucosa, 
and the mucosa (Figure 1.1A).1,2 The serosa is the outermost layer of the intestine and 
is responsible for providing a lubricated barrier separating the inner layers of the 
intestine from the abdominal cavity.1,2 The serosa surrounds the muscularis propria, a 
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layer of smooth muscle that is organized into an outer longitudinal layer and an inner 
circular layer.1,2 These muscle layers work together with the intramural enteric nervous 
system to produce peristaltic contractions that aid in the transport of food along the 
length of the intestine.1,2 The muscularis propria envelops the submucosa, a layer of 
loose connective tissue containing a network of lymphatic vessels, large blood vessels, 
and nerves. The submucosal tissue supplies the overlying mucosa oxygenated blood, 
while also facilitating the distribution of nutrients absorbed by the overlying mucosa.1,2 
The mucosa is composed of three distinct layers. A thin smooth muscle layer 
(muscularis mucosae) surrounds a layer of connective tissue containing fibroblasts, 
myofibroblasts, pericytes, endothelial cells, smooth muscle cells, immune cells, and 
neurons (lamina propria).3 The inner most layer of the mucosa is a monolayer of 
polarized columnar epithelial cells.1,2 The cellular composition of the intestinal 
epithelium is complex, consisting of a variety of cell types that work in concert to carry 
out nutrient absorption while still maintaining epithelial barrier function (Figure 1.1B).4-7 
 
The small intestinal epithelium 
The absorptive role of the small intestinal epithelium is reflected by both its 
architecture and cellular composition. Villi, which are finger-like projections that protrude 
into the luminal space, greatly increase the absorptive capacity of the small intestine by 
increasing the mucosal surface area available for nutrient uptake.4-7 Villi are 
predominately composed of specialized absorptive enterocytes that contain microscopic 
cellular membrane protrusions termed microvilli, which further enhance the absorptive 
capacity of the intestinal epithelium. Villi also contain mucus secreting goblet cells, 
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hormone secreting enteroendocrine cells, and tuft cells, which are thought to play a role 
in sensing luminal contents (Figure 1.1B).4-8  
The intestinal epithelium is frequently exposed to damaging agents passing 
through the luminal space, necessitating constant regeneration.9 Remarkably, the 
intestinal epithelium is capable of near complete renewal every 5-7 days, making it the 
most regenerative tissues in the mammalian body.9 This regenerative process is driven 
by a pool of intestinal stem and progenitor cells located in intestinal crypts, which are 
epithelial invaginations that extend from the villi into the underlying lamina propria.4-7 
Intestinal stem cells (ISCs) located at the very base of the crypt divide 
approximately every 24 hours to produce transit amplifying progenitor cells.10 These 
progenitor cells divide every 12-16 hours while undergoing differentiation as they 
migrate upwards out of the crypt towards the villi.10 After 2-3 cellular divisions, upon 
reaching the crypt-villus junction, progenitors terminally differentiate into either 
absorptive enterocytes, tuft cells, or one of the three secretory lineages (Figure 1.1B).11 
Newly produced post-mitotic cells emerging from the crypts constantly replace damaged 
cells being sloughed off the villi tip into the intestinal lumen.12 This conveyor belt-like 
flow of cells from the crypt base to the villus tip ensures constant replacement of 
damaged cells in the villi and represents an effective mechanism for maintaining the 
absorptive capacity and epithelial barrier function of the intestinal epithelium (Figure 
1.1B).12 The only cell type that does not follow this upward migration pattern is the 
Paneth cell.13 Paneth cells are produced in the transit-amplifying progenitor cell zone 
and initiate their downward migration in part through repulsive cues mediated by Ephrin 
signaling.14 Mature Paneth cells reside in the crypt base, intercalated among ISCs, 
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where they play a role in maintaining the stem cell niche through the secretion of 
antimicrobial peptides as well as of mitogens and morphogens that enhance stem cell 
function.14-17 
In summary, nutrient absorption is carried out by post mitotic cells residing in the 
villi, intestinal regeneration is initiated by intestinal stem cells, and tissue expansion is 
carried out by robustly proliferating progenitor cells that differentiate to produce all post-
mitotic lineages in the intestinal epithelium.13 
 
The intestinal epithelial response to radiation damage 
The highly proliferative nature of the intestinal epithelium under normal conditions 
makes it relatively sensitive to DNA damaging agents including radiation and 
chemotherapy.18 Importantly, following damage-induced intestinal epithelial cell (IEC) 
loss, ISCs mount a robust regenerative response to re-establish epithelial barrier 
function.19 In the field of ISC biology, the administration of high doses of radiation (12-
14Gy) to the small intestine is considered to be the “gold standard” for studying ISC 
mediated epithelial regeneration following injury.20  
Radiation is an ideal cytotoxic agent because it can be accurately dosed, acutely 
administered, and the biological response of the small intestine to the damage it imparts 
has been thoroughly studied.20 Acute exposure to high doses of radiation results in the 
direct formation of double stranded DNA breaks (DSBs) and reactive oxygen species 
(ROS).21 Radiation produces ROS primarily by splitting water in a process termed 
radiolysis.22 Radiolysis of water occurs as a chain reaction in which a water molecule is 
sequentially converted to a hydroxyl radical, hydrogen peroxide, superoxide radical, and 
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finally into oxygen.22 The intermediate species of this chain reaction, termed free 
radicals, are highly unstable and damage cells by reacting with various cellular 
components, including membranes, DNA, and proteins.22 Unsaturated fatty acids 
present in the cell membrane and the membranes of organelles react with ROS to 
produce lipid peroxides resulting in decreased membrane fluidity, increased membrane 
permeability, a reduction in bilayer thickness, and membrane blebbing.23,24 ROS also 
oxidatively damage DNA, resulting in the formation of DNA lesions that are difficult to 
repair. While the majority of oxidized bases are removed successfully by the base 
excision repair pathway, in some cases nucleotide mutagenesis and/or deletions occur 
during the repair process.25 Additionally, ROS induced protein oxidation can result in 
protein fragmentation, cross-linking, and other structural deformations that lead to a loss 
of protein function (Figure1.2A).26 While ROS contribute to radiation-induced damage 
and apoptosis, the formation of DSBs is widely believed to be the predominant 
contributing factor in radiation induced cell death.27 Consequently many studies 
characterizing the response of ISCs to radiation damage have focused on the formation 
and repair of DSBs and not on the damage elicited by ROS.21 Collectively, these studies 
have found that ISCs undergo a predictable damage response involving either DNA 
repair and proliferation or cell death.28  
ISCs subjected to high doses of radiation damage undergo cell cycle arrest 
within the first 6 hours following insult.29,30 During this time period, ISCs initiate DNA 
repair mechanisms and a subset undergo P53 dependent apoptosis.30,31 The 
mechanisms that ISCs employ to repair DSBs is partly dependent on their proliferative 
state.32 Mitotically active ISCs present in S/G2 phase preferentially repair DSBs using 
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homologous recombination (HR).30,32,33 In contrast, ISCs that are not proliferating 
directly re-ligate DSBs in a process termed non-homologous end joining (NHEJ) 
(Figure1.2B).30 Although HR is traditionally considered to repair DNA with higher fidelity 
when compared to NHEJ, emerging evidence suggests that NHEJ is a faster and more 
efficient means of repairing DSBs.34,35 Between 18 and 24 hours post radiation damage, 
ISCs begin to re-enter the cell cycle to initiate intestinal epithelial regeneration.30,36 Upon 
cell cycle re-entry, ISCs that have not accurately repaired their DNA undergo mitotic 
catastrophe, a form of cell death induced by aberrant chromosomal segregation.28 
Conversely, ISCs with accurately repaired DNA re-enter the cell cycle and go on to 
regenerate the intestinal epithelium (Figure1.2C).19,36-38  
Although a comprehensive understanding of the ISC populations capable of 
escaping radiation induced apoptosis and initiating epithelial regeneration is still lacking, 
carefully conducted biomarker based lineage tracing assays performed in concert with 
radiation have provided insight into the composition of this radioresistant ISC pool and 
will be discussed in detail later.11 Additionally, the molecular mechanisms responsible 
for imparting radioresistance within ISCs remain largely unknown, but are partly 
addressed by the works presented in this dissertation.  
 
ISCs: Where are they? 
Early models describing ISC identity  
Early studies established that normal IEC proliferation is restricted to crypt-based 
cells and that cellular migration occurs upward out of the crypts and into the villi, 
supporting the notion that ISCs are located within the crypt.10 The crypt location and 
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composition of the ISC pool, however, has been a topic of intensive study among ISC 
biologists for decades.11 Early theories regarding the identity of ISCs assumed that ISCs 
were behaviorally and phenotypically comparable to adult stem cell populations present 
in other regenerative tissues. Two schools of thought emerged attributing stem cell 
capacity to two different cellular populations: the ‘+4’ model, championed by Potten and 
colleagues and the ‘stem cell zone’ model proposed by Cheng and Leblond.39,40  
The ‘+4’ model attributes stem cell identity to a population of label retaining cells 
(LRCs) residing at the ‘+4’ position as counted from the crypt base upward.41 Briefly, 
label retention assays are performed by administering detectable nucleotide analogs for 
a period of time sufficient to ‘label’ a significant fraction of cells present in a tissue. 
Labeling occurs as the nucleotide analog is incorporated into the cell’s DNA during the 
DNA synthesis portion of the cell cycle. Following this labeling period, the administration 
of the nucleotide analog is halted and the ‘label’ is allowed to be passively lost through 
proliferation-dependent dilution.42 Thus, label retention refers to the ability of a cell to 
retain the detectable nucleotide analog over time. At the cellular level, label retention 
can be achieved by two mechanisms, asymmetric chromosomal segregation or a slowly 
cycling/quiescent proliferative state.  
Cells residing at the ‘+4’ position were initially described as being both label 
retaining and proliferative, suggesting that this cell type asymmetrically segregates its 
DNA during cellular division, keeping its original copy and passing on the newly 
produced genetic material to daughter progenitor cells.43 Originally described as the 
‘immortal strand hypothesis’, asymmetric DNA segregation was proposed to mark stem 
cell populations because presumably it protects the genomic integrity of adult stem cell 
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populations over the lifetime of an organism by preventing the accumulation of 
mutations acquired during DNA replication (Figure1.3).44 Notably, no studies have 
corroborated the existence of a cellular population capable of asymmetric chromosomal 
division in the intestine since.45,46  
Another observation supporting the notion that cells occupying the ‘+4’ cell 
position represent ISCs is that they display high sensitivity to radiation damage.39 To a 
similar end, adult stem cell populations are thought to display high sensitivity to genomic 
perturbations and rapidly undergo apoptosis following insult to prevent the propagation 
of mutations incurred during DNA repair.47 In recent years, however, the radiosensitive 
nature of cells residing in the ‘+4’ position has been contested. In fact, many 
subsequent studies describe cells residing in the ‘+4’ position as being radioresistant.11  
In contrast to the ‘+4’ model, the ‘stem cell zone’ model attributes stem cell 
identity to crypt based columnar cells (CBCs), slender cells located between and just 
above Paneth cells at the very base of the crypt.6 CBCs are proliferative, 
undifferentiated, and possess a high nuclear to cytoplasmic ratio, a cellular phenotype 
commonly observed in adult stem cell populations.40 In this model, CBCs occupy the 
“stem cell permissive” zone at the very crypt base, giving rise to progenitor cells that 
migrate upward and begin to differentiate at cell position ‘+5’ after losing contact with 
Paneth cells.40  
These two models describing stem cell identity and behavior persisted for 
decades in the absence of technologies that allowed for the direct assessment of the 
defining properties that constitute “stemness”, which are self-renewal capacity and 
multipotency.48 Self-renewal capacity is the ability of a stem cell to undergo limitless 
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cellular division while maintaining an undifferentiated state. Multipotency is the ability of 
a stem cell to produce progeny capable of differentiating into all lineages present in its 
resident tissue.49 Contemporarily, self-renewal capacity and multipotency are assessed 
using in vivo lineage tracing and in vitro culture of putative stem cell populations.50 
 
Current methods for assessing ISC capacity 
A commonly employed technique for assessing stemness in vivo is lineage 
tracing. In lineage tracing assays, a potential stem cell population is labeled with a 
heritable genetic mark (such that the labeled cells and their clonal offspring carry the 
mark) and clonal persistence and composition is assessed over time.51 A cell that is 
capable of giving rise to long-lived clones containing all lineages present in its resident 
tissue is considered to be a stem cell.51  
An alternative method of assessing stemness is in vitro culture of suspected 
stem cell populations under stem-permissive conditions.  Briefly, single potential stem 
cells are isolated and placed into defined culture conditions that mimic the endogenous 
stem cell niche environment.52 Cells that are able to produce long-lived, multicellular 
cultures containing all post mitotic lineages present in their native tissue are considered 
stem cells.50 In contrast to lineage tracing assays, in vitro culture assays require the 
research and development of appropriate culture conditions, which can be technically 
challenging to define.50   
Importantly, while both of these techniques assess stem cell potential, their 
success relies on the ability to mark and/or isolate discrete cellular populations. This 
ability can be accomplished by either taking advantage of behavioral traits unique to a 
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cellular population of interest or by using genetic biomarker based animal models. In the 
absence of technologies that allowed for the development of genetically engineered 
animal models, early studies relied on behavioral traits to identify and study ISCs.  
The first study to demonstrate that CBCs represented ISCs relied on a unique 
property of CBCs, their ability to phagocytose dead cellular debris. After the 
administration of 3H-thymidine followed by radiation damage, 3H-thymidine phagocytic 
fragments are observed exclusively within CBCs.7 Overtime, phagocytic fragments 
passing from CBCs to their progeny are detectable in all post mitotic lineages present in 
the intestinal epithelium. This clever lineage tracing technique provided the first direct 
evidence suggesting that CBCs represented multipotent ISCs.7  
Another unique property of ISCs, as well as a variety of other stem cell 
populations, is that they efflux DNA binding dyes (vital dyes) more effectively than other 
cellular populations in the intestinal epithelium.53,54 This property can be used in co-
ordination with flow activated cell sorting (FACS) to preferentially isolate ISCs from the 
intestinal epithelium.53 Commonly referred to as “side population analysis”, the intestinal 
epithelium is dissociated into single IECs and then incubated with vital dyes. During 
incubation, the majority of IECs pick up and retain florescent vital dyes while ISCs 
rapidly remove the dyes from their cytoplasm. Viable IECs that do not demonstrate vital 
dye florescence, referred to as a “side population”, are then isolated using FACS.54 The 
“side population” present in the intestinal epithelium ISCs can be further divided into 
sub-fractions enriched for CBCs (upper side population) and LRCs (lower side 
population), both of which are able to produce multicellular structures termed enteroids 
in culture.54 This study not only demonstrates that the “side-population” present in the 
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intestinal epithelium represent ISCs, but was also the first study to describe a method to 
preferentially isolate CBCs and LRCs from the intestinal epithelium that does not rely on 
the use of genetic biomarkers.  
 An alternative approach to labeling and/or isolating potential stem cell 
populations is the use animal models that rely on genetic biomarkers.11 The 
identification of biomarkers for ISCs has been the focus of many studies over the past 
decade and has yielded results that have furthered our understanding of the identity and 
behavior of ISCs.   
 
The identification of ISC biomarkers: CBCs 
An important finding that facilitated the identification of the first ISC biomarker is 
that canonical Wnt signaling is required for maintaining the proliferative capacity of crypt 
based IECs. The canonical WNT signaling pathway has been very well 
characterized.55,56 In the absence of WNT, cytoplasmic β-Catenin (a transcriptional co-
activator) is targeted for degradation by a complex consisting of axin inhibition protein 2 
(AXIN2), adenomatous polyposis coli gene product (APC), casein kinase 1 (CK1), and 
glycogen synthase kinase 3 (GSK3), thereby inhibiting the transcriptional activities of β-
catenin (Figure 1.4A).55 When WNT is present, a downstream signaling cascade is 
initiated that prevents the destruction of cytoplasmic β-Catenin and allows for its 
translocation into the nucleus where it complexes with transcription factor 4 (TCF4) and 
activates transcription of WNT target genes (Figure 1.4B).55,56  
 In the intestinal epithelium, the genetic ablation of Tcf4, a downstream effector of 
the Wnt pathway, or overexpression of Dkk1, a Wnt signaling inhibitor, results in a 
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complete loss of IEC proliferation, demonstrating that WNT signaling is necessary to 
support ISC proliferation capacity.57,58 Furthermore, the assessment of the gene 
expression profile displayed by cultured human colon cancer cells carrying a loss of 
function mutation in the WNT inhibitor APC (resulting in constitutive activation of 
canonical WNT signaling) revealed a gene expression signature comparable to that of 
healthy crypt based cells.59 This result suggested that the WNT signaling network is a 
major contributor to the gene expression profile of intestinal stem and progenitor cells 
and that WNT signaling targets may represent ISC biomarkers. To determine which 
genes present in the genetic signature of the colon cancer cells were WNT responsive, 
a dominant negative version of TCF4 was used (a genetic manipulation that halted 
constitutive WNT signaling).59 Comparison of the genetic profiles of colon cancer cell 
lines with and without constitutive WNT signaling present yielded a list of differentially 
regulated, potential WNT signaling targets.59 The expression patterns of 80 potential 
WNT target genes were examined histologically and although the overwhelming 
majority of these targets are expressed broadly throughout the crypt base, a few genes 
demonstrated more discrete expression in CBCs.60 One of these genes was the orphan 
G-protein coupled receptor Lgr5.60 In a landmark study, lineage tracing validated Lgr5 
as an ISC biomarker. 
In this study, a targeted Lgr5 knock-in mouse model was created in which a 
construct containing a enhanced green fluorescent protein (EGFP) followed by a 
ribosomal entry site (IRES) and a tamoxifen inducible Cre recombinase (CreERT2) was 
knocked into the Lgr5 locus.60 These Lrg5EGFP-IRES-CreERT2 mice were crossed to mice 
carrying a reporter allele (R26LacZ) to allow for lineage tracing analysis. Upon 
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administration of tamoxifen, LacZ expression faithfully recapitulated endogenous Lgr5 
expression and single LacZ positive CBC cells were observed in the base of the crypt.60 
Over time, these cells gave rise to entire crypt/villi units that contained all major post 
mitotic lineages present in the intestinal epithelium and persisted over the lifetime of the 
mouse, fulfilling the defining characteristics of adult stem cells (self renewal capacity 
and multipotency) and validating Lgr5 as the first bona fide ISC biomarker.60 
Importantly, this study provided the ISC community with the first mouse model that 
allows for the visualization and isolation of ISCs. An important consideration of the 
Lgr5EGFP-IRES-CreERT2 mouse model is that although highest expression of Lgr5EGFP-IRES-
CreERT2 is observed in CBCs, lower levels of EGFP (and presumably CreERT2) 
expression extend beyond the +4 cell position, introducing the possibility that some of 
the long lived lineage tracing events were initiated in ‘+4’ cells residing in the supra-
Paneth cell zone.60 This finding facilitated the identification of additional CBC ISC 
biomarkers including Sox9, Axin2, Ascl2, Olfm4, Rnf43, and Smoc2.61,62 Shortly 
following the identification of the CBC ISC biomarker Lgr5, several groups sought to 
identify biomarkers specific to LRCs residing in the ‘+4’ position. 
 
The identification of ISC biomarkers: ‘+4’ residing LRCs 
The first biomarker reported to enrich for quiescent ISCs in the ‘+4’ position was 
Bmi1, a gene involved in maintaining the self-renewal capacity of hematopoietic, 
leukemic, and neuronal stem cells.63 In the intestinal epithelium, in situ hybridization 
analysis revealed that Bmi1 expression is restricted to the supra-Paneth cell zone. 
Consistent with this finding, lineage tracing events elicited using a Bmi1CreERT2; R26LacZ 
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mouse model primarily initiated in the ‘+4-5’ cell positions and gave rise to a modest 
number of long-lived crypt/villi units over time containing all major intestinal epithelial 
lineages.63 This seminal study was the first to report that cells residing in the ‘+4’ cell 
position also represented ISCs.  
The attribution of Bmi1 expression specifically to the ‘+4’ cell position, however, 
has been challenged by follow-up studies.33,61 Using the same Bmi1CreERT2; R26LacZ 
lineage tracing model, tamoxifen administration was found to initiate lineage tracing 
events in cells occupying crypt positions ranging from ‘+1-15’ and that the Bmi1 
expressing cells present in the ‘+1-5’ position co-express the CBC stem cell biomarker 
Lgr5.33,61 In addition to Bmi1, three additional biomarkers for the ‘+4’ LRC population 
have been reported: Tert, Hopx, and Lrig1. Like Bmi1, however, the specificity of their 
expression to the supra-Paneth cell zone has been challenged.11 
Telomerase reverse transcriptase (Tert) maintains telomere length over the 
course of cellular divisions and its expression is associated with maintaining the self-
renewal capacities of adult stem cell populations.64 To determine if Tert is expressed in 
ISCs, a transgenic reporter mouse model (TertEGFP) was created. In the intestinal 
epithelium, TertEGFP expression is observed predominately at the ‘+5-6’ crypt position. 
Consistent with a non-proliferating cell type (LRCs), TertEGFP expressing cells rarely co-
localize with the proliferative marker KI67.65 Furthermore, it was shown using a novel 
TertCreERT2; R26LacZ mouse model that Tert expressing cells produce rare long-lived 
clones.65 The exclusivity of Tert expression to the supra-Paneth cell zone was 
subsequently contested. In a follow up study, cells expressing the highest levels of 
Lgr5EGFP-IRES-CreERT2 not only exhibited the highest levels of Tert expression, but also the 
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highest TERT enzymatic activity.66 To date, it remains unclear whether the intestinal 
epithelium contains a cellular population expressing higher levels of Tert than those 
found in CBC cells.  
In contrast to Tert, which is reported to mark a very rare cell type (1 in 150 crypt 
sections), Hopx is much more prevalently expressed in the intestinal epithelium and has 
been reported to be a biomarker of quiescent ‘+4’ LRCs.65,67 Hopx is an atypical 
homeodomain-containing protein that is expressed in crypt-based cells along the entire 
length of the small intestine. Comparison of R26LacZ reporter expression present 18 
hours post initiation of lineage tracing events in Lgr5EGFP-IRES-CreERT2 and HopxCreERT2 
models revealed that these populations predominantly reside in different crypt positions. 
While Lgr5 expressing cells localize to positions ‘+0-4’, Hopx expressing cells occupy 
cell positions ‘+2-7’.67 Interestingly, lineage tracing analysis revealed that these two 
populations both produce clonal crypt units (crypt units that are entirely marked by a 
lineage tracing identifier) but at different rates. Lgr5EGFP-IRES-CreERT2 initiated lineage 
tracing events give rise to entire crypt units rapidly (>50% of tracing events producing 
fully labeled crypt units within 1 month), whereas HopxCreERT2 initiated lineage tracing 
took significantly longer (>50% of tracing events producing fully labeled crypt units 
within 3 months).67 Additionally, HopxCreERT2 initiated lineage tracing events frequently 
give rise to single Paneth cells. Taken together, these data suggest that Hopx 
expressing cells represent a mixed population containing both slowly proliferating ISCs 
and committed Paneth cell precursors.67 
 The most recent ‘+4’ biomarker to be identified is Lrig1, a trans-membrane 
protein known to act as a negative regulator of the pro-proliferative ErbB signaling 
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pathway.68 Lrig1CreERT2 driven lineage tracing events predominately initiate in crypt 
positions ‘+3-5’. A fraction of these cells produce long-lived clones. Consistent with 
previous reports describing the label retaining nature of ‘+4’ cells, Lrig1 expressing cells 
demonstrate limited co-localization with the proliferative marker KI67.68 However, as 
with the biomarkers previously discussed, emerging evidence suggests Lrig1 
expression is not as specific to the ‘+4’ crypt position. Flow cytometric analysis utilizing 
a novel LRIG1 antibody demonstrates that all Lgr5 expressing cells co-express 
LRIG1.69 Furthermore, using the same antibody, histological analysis revealed that 
LRIG1 is expressed throughout the bottom half of the crypt with the exception of Paneth 
cells, which lack LRIG1 expression. 69,70  
The overlapping nature of biomarkers reported to be specific to either CBC stem 
cells or the ‘+4’ LRC population is a major point of interest to the ISC community and 
has prompted comprehensive analysis of stem cell biomarker expression patterns.11 
 
Re-evaluating ISC biomarker specificity 
Recently, the expression of biomarkers reported to be specific to ‘+4’ LRCs was 
assessed in cells expressing the highest levels of the CBC stem cell biomarker Lgr5 
using global transcriptomic and proteomic analyses. Surprisingly, Lgr5 expressing cells 
co-express all previously reported biomarkers for the ‘+4’ LRC: Bmi1, Tert, Hopx, and 
Lrig1.61 Additionally, complementary florescent in situ hybridization analysis confirmed 
the presence of ‘+4’ stem cell biomarker expression in CBCs and also demonstrated 
that the expression of these biomarkers extended throughout the progenitor cell zone of 
the crypt, unlike Lgr5 which was found to have a much more restricted expression 
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pattern confined to the crypt base.61 A major limitation to this study is that no direct 
comparisons were made between Lgr5 expressing cells and cells previously identified 
using ‘+4’ biomarker reporter models. Instead, this study compared cells expressing the 
highest levels of Lgr5EGFP-IRES-CreERT2 expressing to cells expressing lower levels of 
Lgr5EGFP-IRES-CreERT2. Although this study clearly demonstrates that Lgr5 expressing cells 
co-express ‘+4’ biomarkers, it does not sufficiently assess whether Lgr5 expressing cells 
express the highest levels of these ‘+4’ biomarkers.  
A recent study, however, addresses this knowledge gap by making direct 
comparisons between cells expressing high levels of Lgr5EGFP-IRES-CreERT2 and cells 
identified using previously described HopxCreERT2 and Bmi1CreERT2 reporter models.71 
Interestingly, while the cellular populations marked by ‘+4’ biomarker reporter alleles 
were found to localize to the supra-Paneth cell zone, they did not express the highest 
levels of their respective transcripts when compared to Lgr5 expressing cells.71 These 
data reconcile studies reporting robust transcript expression of ‘+4’ biomarkers in CBC 
cells with studies describing discrete ‘+4’ biomarker reporter allele activity in the supra-
Paneth cell position. In addition to assessing ISC biomarker expression patterns, this 
study also assessed the phenotypic behavior of cells marked by Lgr5EGFP-IRES-CreERT2 
and HopxCreERT2 reporter constructs. Consistent with previous results, cells identified 
using a Hopx reporter allele demonstrated limited proliferative capacity and gave rise to 
clonal crypt units at a slower rate than Lgr5 expressing cells.71  
In summary, although ‘+4’ biomarker mRNA transcripts are expressed in CBC 
stem cells, the results of studies using proxy reporter alleles to compare CBCs and ‘+4’ 
populations are reproducible and provide insight into the behavioral differences present 
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between these two ISC populations. Why these reporter constructs seem to be prone to 
reproducible artifact remains unclear, necessitating further study. 
 
ISC dynamics: homeostasis and damage induced regeneration 
ISC behavior under normal conditions 
 Studies utilizing ISC biomarker reporter alleles have established CBCs are 
behaviorally distinct from cells residing in the ‘+4’ cell position under homeostatic 
conditions.11 While ISCs residing in the very crypt base (CBCs) are moderately 
proliferative, ISCs residing in the supra-Paneth position (‘+4’ cells) divide much less 
frequently.43,63,67,68 Furthermore, the relative contribution of these cellular populations to 
homeostatic regeneration has been assessed using quantitative lineage-tracing 
analysis. These data demonstrate that while CBC ISCs robustly contribute to epithelial 
renewal under normal conditions, ISCs residing in the supra-Paneth cell zone do so less 
frequently (only giving rise to rare lineage tracing events).72 This finding is indirectly 
supported by a study in which in vivo quantitative clonal fate mapping was used to 
assess the relative contribution of cells residing in the crypt base and the supra-Paneth 
cell zone to homeostatic renewal.73  
Quantitative clonal fate analysis is a method in which ISC dynamics are 
characterized by observing and quantifying lineage tracing efficiencies overtime. To 
perform this analysis, an abdominal imaging window was surgically placed into an 
Lgr5EGFP-IRES-CreERT2 mouse containing a florescent reporter allele.74 Briefly, lineage 
tracing events were initiated in single Lgr5 expressing cells and their initial crypt position 
was recorded. Cells at the very crypt base were termed ‘central cells’ and cells residing 
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in the supra-Paneth cell position were termed ‘boarder cells’. ‘Central cells’ experience 
a survival advantage and demonstrate self-renewal capacity more frequently than 
‘boarder cells’.  While in some instances ‘boarder’ cells were able to self renew and 
produce clonal offspring, they did so at a slower rate and in some cases were passively 
displaced into the transit-amplifying zone.73 While this study fate mapped CBCs and 
cells residing in the supra-Paneth cell zone, it only initiated lineage tracing events in 
Lgr5 expressing cells and never directly assayed the fate of cells identified with in 
studies using previously described ‘+4’ biomarkers. Nevertheless, within the Lgr5 
expressing ISC pool, these data demonstrate cells residing in the CBC cell zone 
contribute more to homeostatic regeneration than those in the supra-Paneth cell zone.  
 
ISC behavior in response to radiation damage 
In addition to studying how ISC populations act under homeostatic conditions, 
many studies have also characterized how these populations respond to damage. As 
previously discussed, the administration of a high dose of radiation results in significant 
IEC loss followed by a robust ISC mediated regenerative response.28 The relative 
contribution of ISCs residing in the crypt base and ‘+4’ position to damage induced 
regeneration has been extensively studied utilizing biomarker reporter allele based 
assays.11 These studies have revealed that Lgr5 expressing CBCs are radiosensitive 
while cells marked by ‘+4’ biomarker proxy reporter alleles are radioresistant.63,65,68,72,75 
Two independents studies have shown that administering high doses of radiation 
(>12Gy) to intestine results in a complete loss of Lgr5EGFP-IRES-CreERT2 expressing 
cells.72,75 Supporting this observation, Lgr5 expressing cells also fail to lineage trace 
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following radiation damage.72 In contrast, radiation damage increases the number of 
lineage tracing events derived from cells marked by ‘+4’ biomarker reporter 
alleles.65,68,72,75 Taken together, these data indicate that cells residing in the ‘+4’ position 
are not the primary contributors to intestinal renewal under homeostatic conditions, but 
they do play an important role in facilitating damage induced regeneration.11  
The composition of the radioresistant cellular populations marked by ‘+4’ 
biomarker reporter alleles is not fully understood. Recall that due to technical limitations, 
the identification of ‘+4’ biomarkers was a necessary prerequisite for the study of LRCs 
residing in this cell position.63,68 Recently, however, the development of innovative 
mouse models has negated the need for biomarkers to study the identity and behavior 
of LRCs under homeostasis and following damage. 
 
LRC behavior under homeostatic conditions 
Early efforts to study LRCs in the ‘+4’ position utilized biomarker-based assays to 
enrich for this cell type because at the time technologies that allowed for the isolation, in 
vitro culture, and in vivo lineage tracing of cellular populations were biomarker 
dependent.11 Problematically, although ‘+4’ biomarker reporter alleles can be used 
enrich for LRCs, they also mark contaminating cell types including CBCs and progenitor 
cells as previously discussed.11 In contrast, label retention assays allow for the direct 
detection of LRCs. However, a prerequisite for their detection is tissue fixation, 
precluding the possibility of LRC isolation for culture and gene expression analysis or 
LRC initiated in vivo lineage tracing assays.  
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A new mouse model has recently emerged which eliminates the need for tissue 
fixation to study LRCs. Using the Cyp1a1-H2BYFP reporter allele, expression of H2BYFP 
is acutely induced using ß-naphthoflavone throughout the intestinal epithelium, with the 
exception of Paneth cells which remained unlabeled.76 Following labeling, H2BYFP 
expression is lost in the intestinal epithelium through successive rounds of cellular 
division in proliferating cells, but importantly is retained in slowly dividing/quiescent cell 
types. Consistent with previous reports, H2BYFP expressing LRCs present after a 10 day 
washout period in this assay primarily localize to the ‘+3-8’ crypt positions.76 Gene 
expression analysis revealed that LRCs express all the previously described ISC 
biomarkers in addition to a subset of secretory lineage transcripts, suggesting that LRCs 
are secretory precursors that may possess stem cell capacity.76  
To address whether LRCs possess stem cell potential, H2BYFP expressing LRCs 
were FACs isolated and subjected to in vitro culture analysis. In vitro culture of LRCs 
resulted in the formation of multicellular structures, termed enteroids, at efficiencies 
similar to Lgr5 expressing CBCs, indicating that this population possesses stem cell 
potential.76 To address whether LRCs exhibit functional stemness in vivo, a novel 
animal model utilizing dimerizable Cre technology was developed to initiate lineage 
tracing events in LRCs. Specifically, the expression of half of a Cre recombinase was 
under the control of a the same ß-naphthoflavone responsive Cyp1a1- loci previously 
described, while the other half of Cre recombinase was made to be constitutively 
expressed throughout the intestinal epithelium. Initiation of lineage tracing events in 
LRCs was achieved by administering a dimerizing agent, AP20187, which combined the 
two Cre subunits to produce a functional Cre recombinase only in LRCs. Contrary to 
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previous reports suggesting that LRCs acted as a stem cell population under normal 
conditions, lineage tracing analysis revealed that LRCs were incapable of producing 
long lived clones and instead primarily gave rise to Paneth cells.76 These data suggest 
that under normal conditions LRCs are secretory progenitors that possess stem cell 
capacity. 
 
Damage induced acquisition of stem cell capacity by secretory progenitors  
The finding that LRCs do not act as a stem cell population under homeostatic 
conditions was surprising given that populations marked by ‘+4’ biomarker reporter 
alleles all lineage trace to some extent under homeostatic conditions. 43,63,67,68,76 
Interestingly, previous studies have suggested that secretory progenitor cells are 
capable of acquiring stem cell capacity following damage.75,77 Supporting this notion, 
LRCs exhibit functional stemness following both chemical and radiation induced injury 
and lineage trace during damage induced regeneration.76 It is important to note that in 
this assay LRCs older than 12 days were incapable of lineage tracing even in response 
to damage, suggesting that they lose ISC capacity at some point during their transition 
into a Paneth cell fate.76 In addition to LRCs, two additional populations with 
characteristics of secretory progenitors demonstrate damaged induced stemness.  
A subset of progenitor cells expressing the notch ligand Dll1 represent secretory 
progenitors that give rise to a mixed populations of enteroendocrine, goblet, and Paneth 
cells under normal conditions.75 However, when the intestine is subject to injury, Dll1 
expressing cells are capable of initiating intestinal regeneration by reacquiring a stem 
cell state and giving rise to entire crypt-villus units.75 Additionally, a cellular population 
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expressing high levels of the transcription factor Sox9 (Sox9high) has been reported to 
demonstrate damage-induced stemness.77 Under normal conditions, Sox9high cells are 
very slowly proliferating, express the secretory transcripts Chga and Chgb, and fail to 
form enteroids in culture.77,78 However, when the intestinal epithelium is subjected to 
high doses of DNA damage, Sox9high cells become more proliferative and regain the 
ability to form enteroids in culture.77  
The notion that secretory progenitor cells possess stem cell potential, but do not 
ordinarily exercise this potential under homoeostatic conditions has greatly influenced 
our understanding of the resilient nature of ISC pool. These works support a stem cell 
model in which Lgr5 expressing CBCs represent a radiosensitive ‘active’ stem cell 
population (aISC) that carries out homeostatic renewal, while secretory progenitors 
represent a radioresistant ‘reserve’ stem cell population (rISC) that can be called upon 
to facilitate epithelial regeneration following damage induced aISC loss.11  
The mechanisms that facilitate transition from a progenitor to a stem cell state 
are unknown. However, they are likely involve modulating genetic networks that govern 
proliferation and stemness. In this dissertation, I will address the role that the 
transcription factor Sox9 plays in regulating the rISC state, but before doing so it is 
necessary to gain an appreciation for the biology of the Sox family of transcription 






Sox transcription factors as regulators of stemness 
 Sox family proteins are defined by the presence of a characteristic high mobility 
group (HMG) that binds to DNA in a sequence specific manner.79 The HMG domain was 
first discovered in Sry, a critical factor in male sex determination in mammals. In all, 20 
different Sry-related HMG box (Sox) factors have been discovered in mice and humans 
and are grouped based on structural homology outside of their HMG domains into sub-
families A through H.80 Early studies of Sox factors predominately describe the 
numerous roles that they play in cell fate determination during development. However, 
many recent studies have discovered that they also play a pivotal role in supporting 
adult stem and progenitor populations.79  
As transcription factors, Sox factors bind to DNA and are capable of modulating 
the expression of genes involved in proliferation, cell fate specification, differentiation, 
self-renewal capacity, and multipotency.79,81 Sox factors ubiquitously bind with high 
affinity to a common DNA element (A/T)(A/T)CAA(A/T) and are capable of dramatically 
bending DNA to join distant enhancer and promoter regions to exert transcriptional 
regulation.79 Due to common DNA binding specificity, Sox family factors have been 
reported in some contexts to have functional redundancy.80 In most cases, however, 
Sox factors display unique transcriptional activities due to post-translational 
modifications and differential affinities for transcriptional cofactors and flanking 
sequences present outside of the Sox consensus binding sequence. The context 
dependent nature of Sox factor function underlies their utility governing many 
developmental processes in addition to supporting adult stem cell populations.79 Thus 
far, Sox factors have been shown to maintain the potency and self-renewal capacity of 
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adult stem cells in the intestine, nervous system, testis, muscle, hair follicle, pancreas, 
liver, breast, and retina.79,82 
Consistent with their ability to maintain a stem cell state, Sox factors have also 
been shown to be capable of eliciting stemness in differentiated cells.79 Overexpression 
of Sox2 along with Oct4, c-Myc, and Klf4 results in the reacquisition of a stem cell state 
from post-mitotic cells.83 Later studies revealed that of these four factors, only Sox2 and 
Oct4 were necessary for the production of induced pluripotent stem cells when used in 
combination with histone deacetylase (HDAC).84 The ability of Sox factors to elicit a 
stem cell identity when overexpressed with genes that complement their activities is 
further supported by studies conducted in mammary epithelium.85 The overexpression 
of Sox9 along with Slug2 successfully converted post-mitotic luminal mammary cells 
into mammary stem cells capable of long-term mammary gland reconstitution in 
transplantation assays.85  
The ability of Sox factors to induce potency in differentiated lineages highlights 
their importance in maintaining genetic networks that support a stem cell function.79 In 
the intestinal epithelium, very little is known about the intrinsic genetic mechanisms that 
support ISCs and less is known about the mechanisms in which secretory progenitors 
re-acquire stemness following damage.86 Given their ability to revert post-mitotic 
lineages into a stem cell state, Sox factors represent promising candidates for 





The role of Sox9 in development and adult stem cell biology  
Sox9 was first discovered as being the gene responsible for the development of 
campomelic dysplasia, a developmental haplo-insufficiency disorder causing a high 
proportion of male to female sex reversal and defective chondrogenesis resulting in 
skeletal deformation.87 In mice, whole body homozygous genetic ablation of Sox9 
results in heart defects leading to death in utero, whereas heterozygous deletion causes 
mice to die shortly following birth due to defects similar to those observed in humans 
suffering from campomelic dysplasia.88 
This discovery prompted further investigation into the biochemical properties of 
SOX9. Like other Sox family members, SOX9 contains the HMG domain capable of 
binding the Sox consensus binding sequence.89 Uniquely, Sox9 also contains a self-
dimerization domain and a transactivation domain (Figure 1.5A). SOX9 expression and 
function is regulated at the transcriptional, translational, and post-translational level. 
Notably, post-translational modifications of SOX9 have been shown to elicit context 
dependent transcriptional activity (Figure 1.5B).89 For example, phosphorylation by the 
protein kinase A results in a rapid translocation into the nucleus and higher DNA binding 
affinity while ubiquitination by SUMO-1 has been shown to inhibit its transcriptional 
activities.90-92 
While Sox9 has been implicated as a critical factor in many developmental 
events, the focus of this dissertation is how Sox9 maintains adult stem cells in the small 
intestine.89 Studies carried out in animal models that allow for the conditional ablation of 
Sox9 in adult tissues have revealed that it is critical for the preservation of stem cell 
potency and self renewal capacities of stem and progenitor cells in the central nervous 
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system, prostate, breast, skin, hair follicle, and the small intestine.79,89 The identification 
of signaling pathways that Sox9 modulates to support these stem cell populations 
remains an area of active research.  
 
The role of Sox9 in the intestinal epithelium  
In the intestinal epithelium, Sox9 is predominantly expressed in crypt-based stem 
and progenitor cells.93 Interestingly, previous works have shown that discrete levels of 
Sox9 expression mark different cell types.78 The lowest levels of Sox9 expression are 
present in rapidly proliferating progenitor cells, relatively low levels of Sox9 expression 
are found in moderately proliferative aISCs, and highest levels of Sox9 expression are 
observed in a slowly proliferating rISC population.77,78,94  
The function that Sox9 plays in maintaining these IEC populations has been 
partially addressed by studies utilizing conditional Sox9 ablation models. Intestinal 
epithelial specific genetic ablation of Sox9 during development (embryonic day 10.5) 
results in a loss of the Paneth cell lineage and increased proliferation rates of crypt 
based cells.95,96 These results demonstrate that Sox9 not only controls the potency of 
ISCs, but also that it modulates their proliferative capacities. The mechanisms in which 
Sox9 regulates the potency of ISCs remains largely unknown, however, the means by 
which Sox9 represses proliferation in crypt-based IECs have been partially defined. 
In IECs, Sox9 represses two pro-proliferative genetic networks, signaling and 
canonical Wnt signaling.95,96 Gene expression analysis of Sox9 ablated intestine 
revealed a down regulation of Igfbp4, a protein that suppresses the insulin-IGF pathway 
by sequestering IGF thereby inhibiting the expression of pro-proliferative downstream 
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effectors.97 Conversely, overexpression of Sox9 in colorectal cancer cell lines results in 
up-regulation of IGFBP4 resulting in decreased rates of proliferation.97 In the same 
study, chromatin immuno-precipitation of SOX9 in HT29 cells determined that SOX9 
directly binds the IGFBP4 promoter to repress its expression.97  
In addition to driving the expression of insulin signaling inhibitors, Sox9 has also 
been shown to drive the expression of genes that inhibit Wnt signaling. In vivo ablation 
of Sox9 results in increased Wnt signaling target gene expression in part due to a down-
regulation of Wnt-inhibitor genes: Grg1, Grg2, Grg3, and Grg4.78,96 Consistent with this 
finding, overexpression of Sox9 in vitro results up-regulation of the human analogs of 
Grg1-4 (TLE1-4) and ICAT and a down-regulation of Wnt target genes.78,96 Whether 
Sox9 drives the expression of additional Wnt inhibitor genes remains unknown. 
Interestingly, Sox9 has also been described as a downstream target of WNT signaling.93 
Taken together, these data support a model in which Sox9 acts to support a negative 
feedback loop in the WNT signaling pathway.  
The role that Sox9 plays in maintaining the ISC pool is only beginning to be fully 
appreciated. As previously noted, it is apparent that the intestinal stem cell pool 
contains cells occupying an array of proliferative states that demonstrate different 
sensitivity to damaging agents. In this dissertation I address role that Sox9 plays in 







CHAPTER 2: SOX9 MAINTAINS RESERVE STEM CELLS AND PRESERVES 




Background: Reserve intestinal stem cells (rISCs) mediate epithelial regeneration 
following tissue damage. Unlike active intestinal stem cells (aISCs), rISCs slowly cycle 
under homeostatic conditions, allowing for their identification with label retention assays. 
In response to certain epithelial injuries, rISCs convert to an actively dividing state and 
demonstrate multipotency and self-renewal, which are defining properties of stem cells. 
Little is known about the genetic mechanisms that regulate the production and 
maintenance of rISCs. High expression levels of the transcription factor Sox9 (Sox9high) 
have been associated with rISCs. We investigated the role of SOX9 in maintaining 
rISCs. Methods: We performed single-cell analyses to characterize the expression of 
active and reserve ISC markers in Lgr5high cells (aISC) and Sox9high cells (rISC) isolated 
from reporter mice by fluorescence-activated cell sorting. We used label-retention  
assays to determine the proliferative capacity of Sox9high cells.  Lineage tracing 
experiments were performed in Sox9-CreERT2 mice to measure the stem cell 
_________________  
* This chapter previously appeared as an article in the Journal of Gastroenterology. The 
original citation is as follows: Kyle C. Roche, Adam D. Gracz, Xiao Fu Liu, Victoria 
Newton, Haruhiko Akiyama, and Scott T. Magness, “Sox9 Maintains Reserve Intestinal 
Stem Cells in Mouse Small Intestine.” Gastroenterology, no. 6 (November 2015): 149. 
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capacities and radio-resistance of Sox9-expressing cells. Conditional knockout 
(SOX9cKO) and inducible-conditional (SOX9iKO) knockout mice were used to determine 
whether SOX9 was required to maintain label-retaining cells (LRCs) and rISC function.  
Results: Lgr5high and a subset of crypt-based Sox9high cells co-express markers of aISC 
and rISC (Lgr5, Bmi1, Lrig1, and Hopx). LRCs express high levels of Sox9 and are lost 
in SOX9-knockout mice. SOX9 is required for epithelial regeneration following high-
dose irradiation. Crypts from SOX9-knockout mice have increased sensitivity to 
radiation, compared with control mice, which could not be attributed to impaired cell 
cycle arrest or DNA repair. Sox9 limits proliferation in LRCs and imparts radiation 
resistance to rISCs in mice. 
 
Introduction 
 Radiation therapies and many chemotherapeutics treat cancer by targeting 
rapidly dividing cells, but also have off-target effects that damage normal cells in highly 
proliferative tissues such as the intestinal epithelium.98 Consequently, the majority of 
patients undergoing radiation treatment to the abdomen develop acute enteritis due to 
apoptosis of rapidly proliferating crypt-based cells.18,98 Similarly, accidental or combat 
exposure to high-doses of radiation can result in GI Syndrome, which is characterized 
by massive mitotic arrest, apoptosis, and the clinical sequelae associated with the loss 
of epithelial barrier function.18,99  
Radiation damage studies in animal models have uncovered radio-resistant stem 
cells that are defined by their slowly proliferating or quiescent states and primarily 
localize to the +4-5 cell position from the base of the crypt.11 These radio-resistant stem 
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cells are very rare and have been shown in a number of studies to act as a ‘reserve’ 
stem cell (rISC) population when the more abundant ‘active’ or rapidly dividing stem cell 
(aISC) population is depleted.11 The genetic and cellular mechanisms required for rISC 
production and maintenance are unknown. Elucidating these mechanisms could have a 
profound impact on developing new interventions to protect against damage and 
promote epithelial repair in a number of intestinal-related health conditions. 
In the past decade, efforts have been made to develop models that enable 
identification and isolation of rISCs to study their contribution to epithelial regeneration.  
Many of these studies have focused on identifying unique genetic biomarkers useful for 
distinguishing between aISCs and rISCs.11 Lgr5 was one of the earliest ISC biomarkers 
to be validated by genetic lineage tracing and its expression is generally considered to 
be highly restricted to aISCs that are intercalated between Paneth cells at the crypt 
base.60 Since then, a number of biomarkers have been reported to mark rISCs including 
Bmi1, Hopx, Tert, Lrig1, and high levels of Sox9. 63,65,67,68,72,77 However, a recent study 
reported overlapping expression of these biomarkers with the aISC biomarker Lgr5 
suggesting that these markers may not be as useful as previously thought for 
discriminating between active and reserve ISC states.61  
A less controversial functional marker of rISCs is their slowly-dividing or 
quiescent nature, which can be assayed based on nuclear retention of detectable 
nucleotide analogs.76,100 A modification of this assay using Histone 2B-YFP transgenic 
mice has recently demonstrated that quiescent, label-retaining cells (LRCs) function as 
secretory progenitors that predominantly give rise to Paneth cells under homeostatic 
conditions, but also exhibit plasticity and function as rISCs following radiation-induced 
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injury.76 A key property that distinguishes aISCs from rISCs is that aISCs are radio-
sensitive and undergo apoptotic death while rISCs are radio-resistant and capable of 
surviving exposure to high doses of radiation.11  
While rISCs can give rise to aISCs, the reverse has also been shown and 
highlights the dynamic relationship between these two ISC states.33,67 It is unclear 
whether this state transition follows a progression through stereotyped gene expression 
patterns characterized by enrichment or de-enrichment of the classical aISC and rISC 
biomarkers. What is clear is that the state transition is characterized by changes in 
proliferative capacity.11 The genetic mechanisms that regulate this process are likely the 
key to understanding how tissues like the intestine maintain a diverse pool of ISCs that 
have different phenotypic behaviors during homeostatic epithelial renewal and injury-
induced regeneration. Our work and others have shown that the SOX9 transcription 
factor regulates proliferation and is associated in a dose-dependent manner with 
different stem/progenitor populations in the small intestine and colon.77,78,94-96 
In vivo, cells expressing high levels of the transcription factor Sox9 (Sox9high) 
exhibit extremely rare staining with the general proliferative marker KI67 and 
demonstrate gene expression patterns that are consistent with rISCs and some 
secretory lineages.77,78,94 While FACS-isolated Sox9low cells actively divide and maintain 
functional stemness in vitro, Sox9high cells divide very infrequently and are incapable of 
growing in culture conditions that recapitulate endogenous ISC niche signaling.77,94 
Interestingly, during the regenerative phase following irradiation damage, Sox9high cells 
express genes associated with cell cycle re-entry, DNA repair, and anti-apoptosis and 
importantly, acquire functional stemness in culture.77 Together these reports provide 
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strong evidence that Sox9 plays a role in rISC biology. In the present study, we use a 
combination of single-cell gene expression analysis, Sox9-lineage tracing, and intestinal 
epithelial SOX9 ablation, to determine whether SOX9 is directly responsible for 
generating and maintaining the rISC state.   
 
Results 
Sox9high cells demonstrate a secretory progenitor/rISC signature.  
Cells expressing the highest levels of Sox9 have been shown at the population 
level to co-express rISC biomarkers and secretory transcripts, suggesting population 
heterogeneity.77,78,94 We sought to determine whether the Sox9high population is a mixed 
population or a homogeneous population with characteristics of both ISCs and 
differentiated lineages. We conducted single-cell gene expression analysis on Sox9high 
cells to compare and contrast expression patterns to those observed in cells expressing 
high levels of the ISC biomarker Lgr5, which primarily marks aISCs (Lgr5high) (Table 
2.1).60 Crypt-enriched preparations from Lgr5EGFP and Sox9EGFP reporter mice were 
used to FACS-isolate Lgr5high and Sox9high cells for single cell gene expression analysis 
of ISC and lineage-specific gene expression patterns using qPCR (Figure 2.1A,D; 
Figure 2.2A, Table 2.2).  
 Principal Component Analysis is a method of graphically representing multiple 
variables simultaneously on a two-dimensional plot. In single cell gene expression 
analysis, PCA is useful in assessing the heterogeneity of gene expression patterns 
present within cell populations of interest. Individual cells are plotted based on their 
gene expression patterns. The closer cells are together on a principle component plot, 
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the more similar their gene expression patterns are.101 Our data show at the single cell 
level that Lgr5high cells are relatively homogenous by Principal Component Analysis 
(PCA) based on their relatively tight grouping when compared to the Sox9high cell 
population (Figure 2.2B).   
 All Lgr5high cells express aISC biomarkers Lgr5 and Sox9 and nearly all 
Lgr5high cells express aISC biomarkers Lgr4, and Ascl2 (Figure 2.2C). Consistent with 
ISCs, Lgr5high cells generally lack expression of biomarkers associated with 
differentiated absorptive (Sis), enteroendocrine (Tac1) and goblet cells (Muc2) (Figure 
2.2D). Interestingly, all Lgr5high cells express Paneth cell biomarker Lyz2 and a minority 
expresses Defrs-1 suggesting that these biomarkers may not be restricted to the Paneth 
cell lineage at the mRNA level (Figure 2.2C,D). Consistent with gene expression 
analysis conducted at a population level, nearly all single Lgr5high cells express high 
levels of biomarkers classically associated with rISCs including Bmi1, Lrig1, Hopx, and 
Dll1 (Figure 2.2C).61 
 PCA bisects Sox9high cells into distinct populations when Lgr5 expression status 
is used as a distinguishing criterion (Figure 2.2B). A fraction of crypt-enriched Sox9high 
cells (40%) express Lgr5, while the remaining Sox9high cells do not (60%)(Figure 2.3). 
Further analysis indicates that Sox9high:Lgr5pos cells co-express aISC biomarkers Lgr4 
and Ascl2, and rISC biomarkers Bmi1, Lrig1, and Hopx (Figure 2.2C). Ascl2 expression 
is nearly absent in Sox9high:Lgr5neg cells and only a small fraction of these cells express 
the aISC biomarker Lgr4 and other rISC biomarkers that were analyzed (Figure 2.2C). 
Although Sox9high cells are heterogeneous with respect to Lgr5 expression, most exhibit 
expression of secretory lineage genes including Chga (98%), Chgb (87%), and Dll1 
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(51%) (Figure 2.3).  The gene expression pattern in the Sox9high:Lgr5pos population is 
comparable to previously described secretory progenitor LRCs that express a set of 
aISC and rISC biomarkers and the secretory transcripts Chga and Chgb (Figure 2.2E).76 
These data suggest that Sox9high:Lgr5pos cells may represent previously described 
LRCs that act as rISCs following damage.76 
 
Label-retaining rISCs express high levels of Sox9 
To directly test whether Sox9high cells are LRCs, we carried out a label-retention 
assay in Sox9EGFP reporter mice (Table 2.1). For this assay, all cells in the intestinal 
epithelium were labeled with a detectable nucleotide analog (EdU) over the course of 28 
days by osmotic mini-pumps (Figure 2.4). In this assay, only cells having undergone a 
proliferative event over the 28-day EdU administration period are labeled and thus very 
long-lived LRCs and post-mitotic Paneth cells remain unlabeled. The intestinal 
epithelium was then allowed to undergo a washout period, during which time EdU 
labeling was passively lost either through sloughing of differentiated lineages into the 
lumen or proliferation-dependent dilution. EdU-labeled cells that remained after a 10-
day washout period were considered LRCs in agreement with previous definitions.76,100 
The level of Sox9 expression in LRCs was characterized by assessing EdU expression 
by flow cytometry in Sox9EGFP populations (Figure 2.1B). Contaminating Paneth cells, 
which are long-lived and remain labeled by EdU, were conveniently excluded from this 
analysis because they do not express the Sox9EGFP transgene.78,102 Consistent with 
previous reports, we confirmed that non-Paneth LRCs predominantly localize to the +4 
to +7 crypt position (Figure 2.5).76,100 Flow cytometric analysis demonstrated that 
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Sox9high cells exhibit the highest incidence of label-retention (Figure 2.6A). The LRC 
distribution among Sox9 expressing populations was then calculated by accounting for 
relative abundance of Sox9sublow, Sox9low, and Sox9high populations, revealing that 70% 
of LRCs are Sox9high (Figure 2.1B & Figure 2.6B,C). These data demonstrate that most 
LRCs (70%) express high levels of Sox9.   
 
SOX9 is necessary for the maintenance of LRCs 
A number of studies have established that high levels of SOX9 inhibit 
proliferation in the intestinal epithelium.77,78,95,96 These findings suggest that SOX9 might 
be controlling the proliferative capacity of ISCs in a dose-dependent manner and may 
be responsible for controlling the slowly proliferative/quiescent state of rISCs. To 
determine if SOX9 is necessary for the generation of LRCs, we carried out a label 
retention study in conditional SOX9 knockout mice (SOX9cKO) (Table2.1). In these mice, 
Sox9 was genetically ablated at embryonic day 10.5 specifically in the intestinal 
epithelium (Figure 2.7A,B).95,96 Again, the intestinal epithelium was labeled using 
osmotic mini-pumps subcutaneously implanted in SOX9cKO mice and littermate controls 
(Sox9fl/fl). Pumps were then removed and EdU was allowed to washout for 8 and 12 
days, two time-points that were chosen to flank the 10-day wash out period previously 
used to define LRCs.76,100 LRCs in this assay were defined as EdUpos (LRCs), 
EpCAMpos (Epithelial cells), and Lysozymeneg (Non-Paneth cells). Following both 
washout periods, SOX9 deficient intestines contained markedly lower numbers 
(between 80% and 95% reduction) of LRCs indicating that SOX9 plays an essential role 
in the maintenance of LRCs in vivo (Figure 2.8A,B). To determine if continued SOX9 
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expression is necessary for maintaining an LRC state, a label retention assay was 
conducted in inducible SOX9 knockout animals (SOX9iKO). In these mice, Sox9 is 
acutely ablated in the adult intestinal epithelium following tamoxifen administration 
(Figure 2.7A,B). In this assay, Sox9 was ablated during the EdU washout period after 
LRCs had been labeled with EdU. We found that acute loss of SOX9 in pre-existing 
LRCs resulted in the loss of EdU retention demonstrating that sustained SOX9 
expression is necessary for LRC maintenance (Figure 2.8C).  
 
Sox9 expressing cells lineage trace following injury  
 Although our data demonstrate that LRCs express high levels of Sox9, we used 
genetic lineage tracing to determine whether Sox9 is expressed in all rISCs, which 
might include non-LRCs (Figure 2.9A). To test the extent to which Sox9 is expressed in 
rISCs, we utilized a Sox9 lineage tracing animal model (Sox9CreERT2:Rosa-loxp-STOP-
loxp-tdTomato). In this model, a Sox9 promoter drives the expression of CreERT2 
recombinase. Upon tamoxifen administration, the Cre recombinase becomes active in 
Sox9 expressing cells and removes that “STOP” sequence resulting in continuous, 
heritable tdTomato expression (Table 2.1). Sox9-expressing cells have been shown to 
lineage-trace under homeostatic conditions, 103 a finding that we have independently 
confirmed (Figure 2.9B). To promote lineage tracing events from rISCs, we depleted the 
aISC pool using radiation exceeding 12 Gy, a broadly applied method for depleting 
aISCs and eliciting rISC-dependent regeneration.30,65,67,68,72,75 In this assay, Sox9-
expressing cells were genetically marked previous to the administration of 14 Gy of 
abdominal radiation. To negate the possibility that Sox9-positive cells acutely give rise 
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to Sox9-negative rISCs within the 24-hour window preceding irradiation, we also 
initiated lineage tracing at the time of irradiation. In both conditions tested, Sox9-
expressing cells consistently gave rise to crypt/villi units labeled by the lineage tracing 
reporter gene (Figure 2.9B), and notably, complete lineage tracing was observed 
throughout the entire proximal-distal axis of the small intestinal epithelium (>98%) 
(Figure 2.10A,B). While the Sox9CreERT2 allele driving the lineage tracing cannot 
distinguish between different Sox9 expressing populations in the crypt, our results 
indicate that the rISC pool expresses Sox9.   
 
SOX9 knockout intestinal epithelium demonstrates a loss of regenerative capacity 
following radiation damage 
While our data demonstrate that rISCs express Sox9, we wanted to determine 
whether SOX9 was required to maintain the ability of rISCs to mediate intestinal 
regeneration following damage. To determine if SOX9 maintains rISC function, we 
challenged SOX9cKO intestinal epithelium with 14 Gy of abdominal irradiation and 
assessed the ability of rISCs to initiate epithelial regeneration using in vivo micro-colony 
assays, which are considered a functional readout of ISC activity.19,37 Micro-colonies are 
defined as proliferative epithelial units that appear 3.5 days post-irradiation, a time point 
in which new epithelium emerging from surviving rISCs in the epithelial depleted 
mucosal space is first observed. In SOX9cKO epithelium, micro-colonies were nearly 
absent 3.5 days following irradiation (Figure 2.11A,C). Epithelial coverage, measured by 
EpCAM immunostaining, was diminished and only present on the villi and flat luminal 
aspects of SOX9cKO tissue (Supporting Figure 2.12A,B). The lack of epithelial 
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regeneration in SOX9cKO intestine was accompanied by severe weight loss requiring 
humane euthanasia at 7-days post-irradiation due to morbidity (Supporting Figure 
2.12C, Table 2.3).  
SOX9cKO mice lack Paneth cells,96 which have previously been shown to support 
ISC function in vitro.16,102 To evaluate the possibility that the impaired epithelial 
regeneration observed in SOX9cKO animals was due to a lack of Paneth cells, we 
acutely ablated SOX9 in the adult intestines of SOX9iKO mice, a process that does not 
affect Paneth cell numbers (Table 2.1, Figure 2.7 & 2.13). Consistent with observations 
made in SOX9cKO animals, the number of micro-colonies present in SOX9iKO was 
markedly decreased, indicating that the impaired regeneration observed in SOX9cKO 
mice is not due to a lack of Paneth cells (Figure 2.11B,D). Together these results further 
support that Sox9 is required for maintaining rISC function. 
 
SOX9cKO intestinal crypts exhibit increased apoptosis after radiation-challenge despite 
normal cell cycle arrest and DNA repair  
Following radiation damage, ISCs avoid apoptosis by undergoing cell cycle arrest 
to repair DNA.28 Given that SOX9 is known to inhibit proliferation, we sought to 
determine whether SOX9 maintains rISC function by preserving the ability of crypt-
based cells to undergo cell cycle arrest. SOX9cKO and control mice were exposed to 14 
Gy of whole body radiation, a dose known to result in sufficient levels of DNA damage 
to initiate apoptosis in ISCs(Table 2.1).30,72,75 Immunostaining for the apoptotic marker 
Cleaved Caspase 3 (CC3) demonstrates increased apoptosis in SOX9cKO crypts at 1, 6, 
and 24 hours post-irradiation (Figure 2.14A). To determine if this increased radio-
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sensitivity was due to impaired radiation-induced cell cycle arrest, we quantified EdU 
incorporation (S-phase) and phospho-Histone H3 staining (M-phase) in SOX9cKO crypts 
following radiation damage. In both control and SOX9cKO crypts, DNA replication was 
halted at 6 hours post-irradiation and a lack of cells present in M-phase was observed at 
1 and 6 hours post irradiation (Figure 2.14B,C). These results indicate that SOX9 is 
dispensable for damage-induced cell cycle arrest. 
Following radiation damage, DNA repair mechanisms fix double stranded DNA 
breaks, allowing for avoidance of apoptosis and continued cell cycle. To determine if 
apoptosis in SOX9cKO crypts is the result of impaired DNA repair mechanisms, we 
performed immunostaining for γH2AX foci, which appear at DNA double-stranded 
breaks after radiation-induced damage and disappear over time as DNA is repaired.104 
Radiation exposure resulted in rapid formation of γH2AX foci, which equivalently 
diminished in SOX9cKO and control crypts over 24 hours (Figure 2.15). These results 
indicate that SOX9 is dispensable for γH2AX-mediated DNA repair. Despite 
competence to arrest cell cycle and repair DNA, SOX9cKO cells still exhibit higher 
incidence of apoptosis (Figure 2.14A) 
 
Discussion  
 Stemness in somatic tissues is classically defined as the functional ability of a 
cell to give rise to all of the post-mitotic lineages of its resident tissue and to produce 
progeny with self-renewing stem cell capacity.11 While the nature of this definition is 
reliant on functional properties, stem cell biology has been largely dependent on the use 
of genetic biomarkers as proxies for cell function.11 Currently, stemness is 
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experimentally demonstrated through in vivo lineage tracing or ex vivo culture of cell 
populations isolated/marked by behavioral characteristics or using ISC biomarker 
reporter alleles.11 The rise in identified ISC biomarkers over the past 5-10 years has 
presented the research community with multiple theories on whether or not ISCs exist in 
distinct states marked by specific sets of genes, or whether stemness in the intestine is 
a relatively plastic property shared across many cell populations expressing different 
combinations of biomarkers.86  
 Emerging studies that highlight the dynamic ability of ISCs to convert between 
actively dividing and slowly dividing proliferation states have forced re-examination of 
biomarker attribution.33,67 Transcriptomic, proteomic, and smFISH analysis have 
demonstrated that many of the biomarkers originally attributed to a rISC population are 
expressed in aISCs (Lgr5high cells).61 Data from our study confirm these findings and 
demonstrate at the single cell level that Lgr5high cells uniformly co-express the rISC 
biomarkers Bmi1, Hopx and Lrig1. Despite the current volatility of rISC biomarker 
attribution, what has become apparent is that mechanisms exist to produce a pool of 
ISCs with functionally equivalent stem cell properties but with different proliferative 
capacities and distinct gene expression patterns.86,105 Attributing biomarkers to aISC 
and rISC populations has occurred largely in the absence of understanding the 
mechanisms that regulate the proliferative capacities that in part define these states. As 
a conceptual framework, the present study examines Sox9, a broadly expressed 
ISC/progenitor biomarker previously identified by our lab from the perspective of its 
functional role in rISCs.   
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rISCs are distinguishable from aISCs based on two phenotypic criteria: 
proliferation rate and sensitivity to damaging agents.11 ISCs residing in the reserve state 
are slowly proliferating/quiescent, a property that can be assessed using label retention 
assays.11 Our study demonstrates that LRCs express high levels of SOX9 and that 
SOX9 is indispensible for LRC maintenance. In addition to regulating cellular 
quiescence, we found that SOX9 also maintains the other defining criterion of rISCs, 
resilience to DNA damaging agents.105 Regardless of Paneth cell presence, we found 
that crypt-based cells become radiosensitive following SOX9 ablation, exhibiting 
increased apoptotic cell death despite no apparent changes in cell cycle arrest or 
γH2AX-mediated DNA repair. Consistent with a radiosensitive phenotype, SOX9 
knockout intestinal epithelium failed to mount a regenerative response following 
radiation damage resulting in a loss of epithelial coverage accompanied by severe 
weight loss. While our results clearly indicate that SOX9 is required to maintain the 
properties that define rISCs, the mechanisms by which SOX9 preserves quiescence 
and radio-resistance remains a point of interest. Previous studies have demonstrated 
that SOX9 is able to repress Wnt signaling and inhibit proliferative capacity, both of 
which have been shown to be involved in maintaining radio-resistance of crypt-based 
cells.78,95,96,106  
Recently it has been demonstrated that high levels of canonical Wnt signaling 
predispose crypt-based cells to radiation-induced apoptosis by enhancing pro-apoptotic 
DNA damage responses in a proliferation independent manner.107 Both in vivo and in 
vitro assays have shown that enhanced canonical Wnt signaling increases radio-
sensitivity, while attenuation of Wnt signaling has the opposite effect.107 The 
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mechanisms SOX9 employs to inhibit Wnt signaling have been explored using in vitro 
overexpression assays. Expression of high levels of SOX9 in vitro has been shown to 
result in a down regulation of Wnt target genes, c-Myc and Ccnd1, and increased 
expression of Wnt-pathway inhibitors, Grg/TLE family members and ICAT.78,96 
Conversely, the loss of SOX9 both in vitro and in vivo has been shown to increase 
expression of canonical Wnt target genes.96 Taken together, these studies support the 
interpretation that SOX9 imparts radio-resistance to the ISC pool through repression of 
canonical Wnt signaling.  
In addition to inhibition of Wnt signaling, SOX9 might regulate radio-resistance by 
controlling the proliferative capacity of ISCs.  A common feature among radio-resistant 
cell populations is a slowly proliferating/quiescent state.11 Studies conducted 40 years 
ago indicate that dividing jejunal cells in the early DNA synthesis phase (S-phase) are 
highly sensitive to ionizing radiation and undergo apoptosis at a higher incidence than 
those in other stages of the cell cycle.106 This raises the possibility that heightened 
radio-sensitivity of cells in SOX9cKO crypts may be the result of impaired cell cycle 
control. Increased rates of cell division and crypt hyperplasia observed in SOX9cKO 
intestines supports this interpretation, 95,96 and suggests that high levels of Sox9 might 
promote radio-resistance by limiting proliferation. In this regard, SOX9 has been shown 
to modulate proliferative capacity of intestinal epithelial cells by repressing pro-
proliferative pathways. The ability of SOX9 to repress Wnt signaling has been known for 
some time, 95,96, but recently it has also been demonstrated that SOX9 can repress pro-
proliferative insulin signaling through direct regulation of insulin-like growth factor 
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binding protein 4 gene (Igfbp4).97 Whether SOX9 represses proliferation solely through 
modulation of these genetic networks remains unknown. 
Taken together, our data support a model in which the dynamic interconversion 
between active and reserve ISC states is regulated by SOX9 dosage. Under 
homeostatic conditions, active ISCs convert to a rISC state through up regulation of 
SOX9. Elevated SOX9 doses actively preserve the cellular quiescence of secretory 
progenitor cells, which over time become Paneth cells. Following radiation damage and 
loss of aISCs, rISCs down regulate SOX9 expression to levels that are permissive for 
cell proliferation and acquisition of the aISC state. This model also provides a cellular 
mechanism in which SOX9 is necessary for the production of the Paneth cell lineage 
(Figure 2.16).  
 Our study provides conceptual foundations for the development of hypothesizes 
regarding the genetic mechanisms that control the production and maintenance of the 
rISCs and their reactivation by intrinsic and extrinsic signaling. This becomes important 
from a clinical perspective because the rISCs play a critical role in epithelial 
regeneration and repair after events that deplete aISCs, including ionizing radiation and 
chemotherapy. Our results suggest that developing strategies to transiently increase 
SOX9 levels may prove effective for protection against off-target effects of radiation 
therapies.   
 
Materials and methods 
Mice/genotyping 
Sox9-CreERT2 mice were generated as previously described.108 To generate the 
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Sox9-lineage tracing model, Sox9-CreERT2 mice were crossed to a Cre-dependent 
fluorescent reporter line, ROSA26-loxP-STOP-loxP-tdTomato. Sox9-CreERT2;Rosa26-
loxP-STOP-loxP-tdTomato were used for lineage tracing assays. Sox9EGFP mice are on 
the C57Bl6 genetic background and possess a Sox9EGFP BAC containing ~125kb of 
upstream Sox9 regulatory regions driving EGFP expression.78 Conditional Sox9 
knockout animals (SOX9cKO) (Sox9fl/fl; Vil-Cre) were generated by crossing mice 
carrying Sox9-floxed alleles with mice carrying the Villin-Cre transgene.109 Inducible 
conditional Sox9 knockout animals (SOX9iKO) (Sox9fl/fl; Vill-CreERT2) were generated 
by crossing mice carrying Sox9-floxed alleles with mice carrying the Villin-CreERT2 
transgene. All animals used in these studies were 8-12 weeks old. The Institutional 
Animal Care and Use Committee (IACUC) of the University of North Carolina approved 
all animal studies. 
 
Sox9 lineage tracing assays  
Tamoxifen stocks were prepared by adding 10mg of Tamoxifen (Sigma, St. 
Louis, MO) to a solution containing 100 microliters of 100% ethanol and 900 microliters 
of Sunflower oil (Fisher, Waltham, MA). Tamoxifen was dissolved into solution by 
sonication on ice. Sox9-CreERT2;Rosa26-loxP-STOP-loxP-tdTomato were injected 
intraperitoneally with 2mg of Tamoxifen per 20g of body weight to initiate lineage tracing 





Abdominal and whole body irradiation 
Mice under isoflurane anesthesia were given a single dose of 14 Gy irradiation 
using an XRad 320 irradiator (Precision X-Ray, East Haven, CT) (Filter: 2 mm Al; 47 
cm; 320 kV/s, 10 mA; 2.8 Gy/min). For abdominal irradiation assays, mice were 
positioned in the radiator so only their abdomen was exposed to the field of radiation. 
Following irradiation, mice were given wet food placed on the cage floor for the duration 
of their recovery. Body weight was recorded daily. In compliance with UNC IACUC 
protocols for the humane treatment of animals, euthanasia was performed following a 
20 percent reduction in body weight. Statistical significance of body weight reduction 
was determined by one-way ANOVA.  
 
Tissue preparation for histological analysis 
All experiments were performed using the jejunal section of mouse small 
intestine. To prepare tissue for cryo-sectioning, small intestines were dissected from 
adult mice (>8 wk of age), luminal contents were flushed out with ice-cold phosphate-
buffered saline (PBS), and the intestine was pre-fixed by flushing the lumen with ice-
cold 4% paraformaldehyde (PFA) made in PBS. Intestines were then fixed for 14–18 
hours at 4°C and then placed into a 30% sucrose solution for at least 24 hours at 4°C. 
Tissues were then fileted longitudinally, swiss rolled, embedded in optimal cutting 
temperature medium (Tissue Tek, Torrance, CA), frozen on dry ice, and stored at 
−80°C until sectioning. Thin sections (8 µm) were cut on a cryotome and placed onto 




Sections were washed three times in PBS to remove optimal cutting medium. 
Sections were then placed in a slide mailer containing Reveal Decloaker (Biocare 
Medical, Concord, CA) and subjected to antigen retrieval by incubating them in a 
pressure cooker at 120°C for 30 seconds and 95°C for 10 seconds. Following antigen 
retrieval, sections were washed three times with PBS and incubated in Dako protein 
block (Dako; Carpinteria, CA) for 30 min at room temperature to prevent non-specific 
binding. Primary antibodies were diluted in Dako diluent, (Dako; Carpinteria, CA) and 
applied to the sections, which were incubated either at room temperature for 2 hours or 
overnight at 4°C. Dilutions were as follows: αCD326/EpCAM (rat, 1:500, BioLegend, 
San Diego, CA), αLysozyme (donkey, 1:100, Santa Cruz, Santa Cruz, CA), αSox9 
(rabbit; 1:500, Millipore, Billerica, MA), γH2AX (rabbit; 1:500, Cell Signaling, Danvers, 
MA), Cleaved Caspase-3 (rabbit, 1:500, Cell Signaling, Danvers, MA). Following 
primary antibody incubation, sections were washed with PBS three times. Secondary 
antibodies were diluted (1:500) in Dako diluent and applied to sections for 30 minutes at 
room temperature.  Secondary antibodies used for primary antibody detection include: 
αRabbit-Cy3 (Sigma, St. Louis, MO), αRabbit-Alexafluor 488 (Molecular Probes, 
Eugene, OR) αGoat-Cy3 (Molecular Probes, Eugene, OR), αGoat-488 (Molecular 
Probes, Eugene, OR). Sections were then washed three times with PBS and nuclei 
were stained with Bis-Benzamide (1:10,000). Sections were then washed an additional 
three times with PBS and mounted with coverslips using Hydromount (National 
Diagnostics, Chapel Hill, NC). Images were collected using a Zeiss LSM 700 confocal 
microscope. For all histological assays, statistical significance was determined using a 
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unpaired t-test with a Bonferroni correction.  
 
Tissue dissociation/FACS 
Jejunal epithelium was dissociated and broken down into single cells as 
previously described94. Briefly, mouse jejunum was dissected, flushed with cold PBS, 
longitudinally cut open in ∼5-cm-long pieces, and incubated for 35 min at 4°C in PBS 
containing 3 mM EDTA and 10mM Y27632 (Selleck Chemicals, Houston, TX), to 
release the epithelium from the underlying mucosa and prevent anoikis respectively. 
Following incubation, the tissue was transferred to a 15 mL conical containing 10 mL of 
PBS with 10mM Y27632 and shaken vigorously for 3 minutes (2.5 shakes per second). 
Intact tissue was discarded and dissociated crypts and villi were passed through 100µm 
and 70µm filters to remove villi contaminants. The crypts were then washed twice with 
cold PBS and spun down. Crypts were then re-suspended in Hanks' buffered saline 
solution (HBSS) containing 0.3 U/ml dispase (Fisher, Waltham, MA) and 100µg of 
DNase (Fisher, Waltham, MA) and incubated at 37°C for 10 min, shaking gently every 
minute. Single cells were then passed through a 40-µm filter into ice cold PBS 
containing 10% FBS to remove cellular multimers and quench the dispase respectively. 
Single cells were washed with ice cold PBS twice, pelleted at 1,500 rpm for 5 min in an 
ultracentrifuge, and re-suspended in sort media consisting of DMEM F12 advanced 
media (Life Technologies) containing N2 (Life   Technologies, Carlsbad, CA), B27 (Life   
Technologies, Carlsbad, CA), Glutamax (Life   Technologies, Carlsbad, CA) 
Penicillin/Streptomycin (Life Technologies, Carlsbad, CA), 10mM HEPES (Life   
Technologies, Carlsbad, CA), 10µM Y27632 (Selleck Chemicals, Houston, TX), and 
	  49	  
500mM N-acetyl-cysteine  (Sigma, St. Louis, MO).  Cells were then stained with primary 
conjugated antibodies on ice for one hour. Crypt enriched single epithelial cells isolated 
as described above were stained with 10 µl rat anti-mouse CD326 Alexa 647-
conjugated (1:100, BioLegend, San Diego, CA) in 1 ml of sort media for 1 hour on ice to 
allow for the isolation of epithelial cells. The cells were washed twice with cold 
Advanced DMEM/F12 prior to FACS and placed into ice-cold sort media containing 
Annexin V Pacblu (1:100, BioLegend, San Diego, CA) and Sytox Blue (1:500, Life 
Technologies, Eugene, OR) to exclude dead/dying cells. All FACS experiments were 
conducted on a MoFlo XDP cytometer (Dako/Cytomation, Carpinteria, CA). Cells were 
kept on ice throughout the sort and collected into 500 µL of ice-cold sort media. Cells 
were then either subjected to single cell gene expression analysis or EdU analysis as 
described below.  
 
Cell proliferation and LRC assays  
For cell proliferation assays, control and conditional SOX9 knockout mice were 
injected intraperitoneally with 100µg/25g body weight EdU (5-ethynyl-2’-deoxyuridine) 
(Life Technologies, Carlsbad, CA) in PBS, and sacrificed one or two hours post-
injection. To identify label retaining cells, control and conditional SOX9 knockout mice 
were implanted subcutaneously with osmotic mini-pumps (Alzet, Cupertino, CA) 
containing 115 mg EdU suspended in 100 microliters of a 50:50 solution containing 
DMSO:PEG300. Mice implanted with osmotic pumps were treated for 28 days, a time 
period that results in near complete labeling of the intestinal epithelium. Following EdU 
labeling, pumps were surgically removed and EdU was allowed to washout for 8-12 
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days. For both cell proliferation and LRC assays, jejunal intestines were harvested and 
processed for either histology or FACS as described above. For histology, sections 
were then washed three times with PBS and stained for EdU using a Click-it EdU kit 
(Life Technologies, Eugene, OR) with an Alexa-488 fluorophore as per the 
manufacturer’s instructions. Following EdU staining, slides were washed three times 
with PBS and subjected to further histological analysis. For FACS-isolated cells, EdU 
was detected using a Click-it EdU flow cytometry kit (Life Technologies, Eugene, OR) 
with an Alexa-647 fluorophore. Cells were subsequently analyzed for EdU positivity 
using a CyAn flow cytometer (Dako/Cytomation, Carpinteria, CA). Statistical 
significance was determined using a paired t-test. 
 
Micro-colony assays.  
Micro-assays were performed as previously described.37 Briefly, 3.5 days after 
subjecting intestines to 14 Gy of abdominal irradiation, mice were given a 2-hour pulse 
of EdU to label proliferating cells. Jejunal tissue was then harvested and stained for 
EdU as described above. Micro-colonies in this assay were defined as epithelial units 
(EpCAM positive units) containing 5 or more EdU positive cells. Micro-colonies were 
quantified over the length of the entire jejunal swiss roll. The length of jejunal swiss rolls 






Single cell analysis and qPCR 
 For single cell gene expression analysis, cells were sorted as described above 
and applied to either a 5-10 µm or 10-17 µm C1 auto-prep integrated microfluidics chip 
(Fluidigm, San Francisco, CA) to generate cDNA libraries.  Specific cDNA transcripts 
were pre-amplified using the Taqman (Life Technologies, Eugene, OR) probe sets 
targeting genes of interest (Table 2.2). The specific target amplified (STA) libraries were 
applied to the Biomark HD microfluidics chip (Fluidigm San Francisco, CA) to assess 
relative gene expression levels by qRT-PCR using the same Taqman probe sets that 
were used for the STA. Data was analyzed using Singular v3.0 software (Fluidigm) and 
delta-Ct values were calculated based on the limit of detection (LOD), 35 cycles as per 









CHAPTER 3: SIGNIFICANCE AND IMPLICATIONS OF WORK 
 
rISCs isolation strategies  
The use of biomarkers to isolate ISCs residing in different states 
 Many studies over the past decade describing stem cell populations in the 
intestinal epithelium have relied on the use of ISC biomarkers.11 While these studies 
report that CBC stem cells (aISCs) and stem cells residing in the supra-Paneth cell 
position (rISCs) can be distinguished from each other based on biomarker transcript 
expression, recent work challenged this discovery by demonstrating that cells 
expressing the highest levels of aISC biomarker Lgr5 also express all rISC biomarkers 
at the population level.61 A weakness of gene expression analysis conducted at the 
population level, however, is that it is impossible to assess whether the observed gene 
expression is the product of a homogenous population of cells all demonstrating 
transcript expression or of a heterogeneous population in which only a fraction of cells 
express the transcript of interest. Consistent with previous studies, the data presented 
in Chapter 2 demonstrate at the single cell level, all aISCs express traditional rISC 
biomarkers.71  
These data suggest that gene expression analysis cannot be used to assess 
rISC identity or abundance. Instead, the evaluation of rISCs should rely on the 
assessment of the behavioral phenotypes associated with rISC populations: 
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radioresistance, a low proliferative index, and stem cell potential. To this end, the 
continued development of technologies that aid in the study of rISCs represents an 
active area of interest to the ISC community.  
 
Improved method for detection of LRCs in non-transgenic mice 
 The label retention assay is the most widely exercised method for the detection 
of slowly dividing rISCs.41,43 The traditional approach for conducting a label retention 
assay involves acutely labeling IECs with a detectable nucleotide analog and 
subsequently allowing the label to washout.76 Typical labeling periods range from 1-5 
days, requiring multiple injections.63,65,68 This labeling method is stressful to the animal 
and is only capable of labeling IECs that have undergone DNA synthesis over the 
course of a relatively short time period (when compared to the lifespan of an LRC). As a 
result, a subset LRCs are not identified using this method because they are capable of 
maintaining a quiescent state during the entirety of the labeling period.76 In the label 
retention assays implemented in Chapter 2, I describe a novel nucleotide analog 
administration technique that is capable of delivering steady doses of EdU for 28 days 
without a single injection. By using this method, I was able to identify >10 times more 
LRCs than in studies utilizing tradition labeling methods (0.11 vs 0.009 LRCs per crypt 
section).76 While this method still requires tissue fixation as a prerequisite for LRC 
identification, it does not require the use of complex genetic backgrounds.  
Importantly, the limitations associated with tissue fixation are becoming less 
significant. Over the last few years, considerable strides have been made in developing 
techniques that allow for RNA isolation from fixed tissues. Most notably, a recent 
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publication has reported the successful isolation of RNA from fixed cells isolated using 
FACs, a result that we have been able to confirm in our own lab (data not shown).110 
The EdU administration technique developed and described in the methods section 
presented in Chapter 2 should be considered when designing future studies that utilize 
EdU based label retention assays for the study of LRCs in adult mice.  
 
Further defining the identity of the Sox9high population 
A subset of Sox9high cells contain a rISC gene expression pattern 
 Previous work demonstrated that cells expressing high levels of the transcription 
factor Sox9 represent a putative rISC population. This population is capable of regaining 
stem cell potential in vitro following damage and co-expresses secretory and ISC 
biomarker transcripts.77,78,94 However, as with any gene expression analysis conducted 
on pooled cells, it is unclear whether the observed expression of secretory and ISC 
biomarker expression is the product of a mixed population of ISCs and secretory cells or 
whether co-expression of these transcripts is pervasive throughout all Sox9high cells. 
The works presented in Chapter 2 add to our current knowledge regarding the 
composition of Sox9high cells by demonstrating that this population sub-divides based on 
ISC transcript expression.  Specifically our work demonstrates that ~60 percent of crypt 
based Sox9high cells lack ISC biomarker expression and likely represent post-mitotic 
enteroendocrine cells, while ~40 percent express both secretory and ISC biomarkers 
and may represent secretory progenitors that possess stem cell capacity. In future 
studies, it may be possible to identify genes that encode for extracellular matrix proteins 
that could be utilized to differentially isolate these sub-populations using FACS. If 
	  55	  
successful, this finding would allow for relative stem cell potential of these 
subpopulations to be assayed in vitro.   
A surprising observation in this single cell analysis dataset presented in Chapter 
2 is that Sox9high cells lacking Lgr5 expression (Sox9high:Lgr5neg) demonstrate a broad 
range of Sox9 mRNA expression levels. The level of Sox9 expression present in 
Sox9high:Lgr5neg cells extends well below the levels of Sox9 mRNA seen in Lgr5high cells. 
This observation could be due to the continued EGFP persistence following a down 
regulation of Sox9 transcription or inappropriate Sox9EGFP reporter activity. To address 
these possibilities, it would be possible further test this Sox9high:Lgr5neg cells for Egfp 
expression. If the Sox9 and Egfp expression levels tightly correlate in this population, it 
would suggest the persistence of EGFP protein following Sox9 down regulation is 
responsible for the observed discrepancy. If levels of Egfp transcript present in 
Sox9high:Lgr5neg are as high as those observed in Sox9high:Lgr5pos cells, it would suggest 
inappropriate reporter activity. In either case, this observation provides insight into a 
consideration that should be noted when using the Sox9EGFP reporter mouse model.  
 
A fraction of Sox9high cells represent LRCs  
 While cells expressing high levels of Sox9 rarely co-localize with KI67, the label 
retaining nature of this population has never been directly assessed. In Chapter 2, I 
report that 30 percent of the Sox9high cells represent LRCs. An important consideration 
of this data is that LRCs “born” during the 10-day washout period are not identified in 
this assay. Consequently, 30 percent likely represents a low estimate of the fraction of 
Sox9high cells that are LRCs. 
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Another lingering question is what fraction of Sox9high LRCs represents post-
mitotic enteroendocrine cells versus potent secretory progenitor cells. Recall that in 
addition to giving rise to Paneth cells, a small subset of LRCs give rise to 
enteroendocrine cells under normal conditions.76 Unfortunately, the stem cell potential 
of Sox9high LRCs was not assessed in Chapter 2 due to the perquisite of tissue fixation 
for LRC identification. In future studies, it would be possible to cross Sox9EGFP mice to 
the previously described Cyp1a1-H2BYFP animal model, which does not require tissue 
fixation for the detection of LRCs. Instead, in this animal model LRCs present following 
the washout period are fluorescently labeled with YFP expression.76 Using this novel 
mouse model (Sox9EGFP;Cyp1a1-H2BYFP), it would be possible perform single cell gene 
expression analysis and in vitro culture assays on Sox9high LRCs and non-LRCs. Note 
that although large spectral emission overlaps are present between EGFP and YFP, 
novel sorting methods have been developed that allow for these florescent profiles to be 
distinguished from one another.111 Furthermore, this model may provide a more 
accurate estimate of what fraction of Sox9high cells represent LRCs, given that DNA 
synthesis is not necessary to “label” cells in Cyp1a1-H2BYFP animals.  
 
Sox9 as an intrinsic regulator of rISCs 
Sox9 expression is a common feature among all rISCs 
 Lineage tracing analysis from Sox9 expressing cells conducted under 
homeostatic conditions has established that aISCs express Sox9. However, previous to 
now, the expression of Sox9 in rISCs has never been formally tested.103 rISCs are 
responsible for initiating intestinal epithelial regeneration following damage induced loss 
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of the aISC pool. Lineage tracing analysis performed in concert with the administration 
of high doses of abdominal irradiation revealed that nearly all (>98%) of rISCs express 
Sox9.  To date, Sox9 is the only known gene to demonstrate expression throughout the 
rISC pool, consistent with the interpretation that Sox9 intrinsically regulates rISC 
function.  
 It’s important to note that lineage tracing assays using tamoxifen inducible 
CreERT2 drivers have limitations.  Studies indicate that tamoxifen and its active 
metabolites can persist for up to 4 days after administration.112 An alternative 
interpretation of the lineage tracing data reported in Chapter 2 is that all rISC express 
Sox9 during damage induced regeneration and may not express Sox9 under 
homeostatic conditions. For instance, if Sox9neg rISCs exhibit de novo Sox9 expression 
in response to radiation damage and are exposed to residual tamoxifen (albeit at much 
lower levels) it would become genetically labeled and give rise to labeled clonal 
offspring. Theoretically, increasing the tamoxifen washout period would prohibit new 
lineage tracing events from initiating during damage induced regeneration. 
Unfortunately, the use of a longer washout period in Sox9CreERT2 lineage tracing mice 
introduces the possibility that Sox9 expressing aISCs contribute to the rISC pool 
previous to irradiation damage (recall that aISCs express Sox9). Namely, rISCs born 
from aISCs during the 4 day washout period would appear to be Sox9pos regardless of 
their Sox9 expression status at time of radiation damage and lineage trace during 
regeneration. Using a long washout period without introducing the possibility of 
artifactual labeling is only viable if the marked population is truly quiescent.  
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 Another limitation of this lineage tracing study is that it was unable to attribute 
rISC capacity specifically to cells expressing discrete levels of Sox9. Although reducing 
the tamoxifen dose used to initiate lineage tracing events in Sox9CreERT2 reporter mice 
could theoretically initiate lineage tracing events only in Sox9high cells, previous attempts 
to do so have failed. Attributing rISC function specifically to Sox9high cells will require 
additional study.  
 
Sox9 is necessary for the maintenance of a quiescent ISC population 
A defining characteristic of rISCs is that they are slowly dividing/quiescent.11 
Label retention assays are the most widely used method of detecting cells 
demonstrating this behavioral phenotype.76 The identity of LRCs has been largely 
resolved. However, the molecular mechanisms governing their production and 
maintenance were previously unknown. Consequently, a major contribution of the data 
presented in Chapter 2 is the identification of a genetic factor that is necessary for 
maintaining an LRC state.  We show that in addition to exhibiting high levels of Sox9 
expression, LRCs require Sox9 for their production and persistence. The implications of 
this finding are significant. Not only does this demonstrate for the first time that Sox9 
regulates LRC identity, but it also provides insight into the role that Sox9 plays in the 
differentiation of the Paneth cell lineage, discussed in detail later.  
Although the data presented in Chapter 2 demonstrate that Sox9 is necessary for 
maintaining a slowly dividing ISC population, the mechanism in which Sox9 does so is 
not addressed. Further study is needed to identify the genetic networks that Sox9 
controls to inhibit proliferation of LRCs. A promising signaling network to investigate is 
	  59	  
the WNT signaling pathway. In the intestinal epithelium, WNT signaling drives 
proliferation, demonstrating highest activity within the crypt base.113 LRCs present in the 
supra-Paneth cell zone likely maintain a non-proliferative state in part through inhibition 
of WNT signaling. Sox9 has already been generally implicated in inhibiting WNT 
signaling in the intestinal epithelium by up-regulating ICAT and Grg1-4, factors that 
prevent TCF4 and β-Catenin from complexing and driving expression of WNT target 
genes.78,96 Further study is necessary to determine if any these WNT inhibitors play a 
role in maintaining quiescence in LRCs. Future studies could assess whether the 
expression of these WNT inhibitors is positively correlated with Sox9 expression levels 
using Sox9EGFP reporter mice, with the expectation that those demonstrating highest 
expression levels in Sox9high cells represent potential regulators of the LRC state.  
 In addition to repressing WNT signaling by increasing the expression of WNT 
inhibitor genes, studies performed in other cell types have demonstrated that SOX9 
represses WNT signaling by directly interacting with β-Catenin and members of the β-
Catenin destruction complex. In Hek293 cells, SOX9 directly binds to the TCF4 binding 
domain of β-Catenin, thereby inhibiting its ability to complex with TCF4 and promote the 
transcription of WNT target genes.114 In Chinese hamster ovarian (CHO) cells, SOX9 
recruits members of the β-Catenin destruction complex into the nucleus to 
phosphorylate β-Catenin, targeting it for degradation.115 Whether SOX9 physically 
interacts with β-Catenin or members of the β-Catenin destruction complex in the 
intestinal epithelium remains unknown, but could be addressed by performing SOX9 co-
immunoprecipitation in IEC lysates and probing for these proteins via Western blot.  
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The role of Sox9 in maintaining radioresistance of ISCs 
A defining characteristic of rISCs is that they are radioresistant.11 The data 
presented in Chapter 2 demonstrate that Sox9 is necessary for supporting 
radioresistance within the rISC pool by inhibiting damage induced apoptosis. However, 
the mechanism in which Sox9 does so remains unclear. Sox9 may inhibit apoptosis 
indirectly by limiting the number of cells undergoing cellular proliferation at the time of 
radiation exposure or directly through inhibition of pro-apoptotic signaling pathways 
post-irradiation.  
A common feature among mammalian tissues is that proliferation rate is 
positively correlated with sensitivity to radiation damage.116 Consistent with this 
observation, slowly proliferating/quiescent cells in the intestinal epithelium are 
radioresistant.65,68,72 Furthermore, the sensitivity of IECs to radiation-induced apoptosis 
is in part dependent upon their position in the cell cycle at the time of radiation damage, 
demonstrating highest radiosensitivity in early S phase.106 Given that the genetic 
ablation of Sox9 increases proliferation rates among crypt based cells and results in a 
loss of quiescent LRCs, its possible that Sox9 promotes radioresistance within the ISC 
pool by limiting the number of actively proliferating ISCs at the time of radiation damage.  
Alternatively, Sox9 may impart radioresistance to ISCs by repressing pro-
apoptotic pathways. Following radiation damage P53 accumulates and drives the 
expression of genes associated with apoptosis, cell cycle arrest, and DNA repair. 
Consistent with its role in balancing apoptosis and repair, irradiated P53 knockout 
animals experience no apoptosis immediately following damage but, subsequently 
undergo accelerated gastrointestinal failure due to rampant mitotic death.30 Thus while 
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P53 drives apoptosis, it also is necessary for maintaining the capacity of cells to 
undergo repair and avoid mitotic catastrophe. While it remains unclear as to what 
mechanistic factors are responsible for influencing the survival outcome of cells 
experiencing damage induced P53 signaling, two models have been purported, 
‘quantitative’ and ‘non-quantitative’.  
The ‘quantitative’ model postulates that the consequence of P53 signaling is 
dependent upon the level of P53 expression induced by damage.117 An assumption of 
this model is that genes associated with cell cycle arrest and repair have promoter 
elements with high P53 binding affinity (activating expression at low [P53]), whereas 
genes associated with apoptosis contain promoters with low P53 binding affinity 
(activating expression at high [P53]).117 This model is supported by studies utilizing 
inducible P53 expression systems. In immortalized human lung epithelial cells, low 
levels of P53 induction initiate cell cycle arrest whereas high levels of P53 induction 
drive apoptosis.118,119 Additionally, overexpression of P53 in un-irradiated human colon 
cancer cell lines induces apoptosis.120 Furthermore, in human derived lymphoblasts the 
expression of P53 target genes is dependent P53 concentration.121 In contrast, the ‘non-
quantitative’ model states that the outcome of P53 signaling is dependent upon the 
presence of ‘collateral’ signaling pathways. In this model the targets of P53 signaling 
are the same irrespective of P53 levels and that the transcription of P53 target genes is 
dependent upon the presence of additional signaling molecules that either drive 
apoptosis or cell cycle arrest and repair.117 For example, overexpression of MYC in 
human colon cancer cell lines enhances P53 induced apoptosis by competing with P53 
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for binding sites in promoters of genes associated with cell cycle arrest, thus promoting 
cell death.122    
Although Sox9 has not yet been shown to influence P53 signaling in the intestinal 
epithelium, increased rates of apoptosis are observed 6 hours following radiation 
damage (at the peak P53 induced apoptosis). This result is consistent with the 
hypothesis that Sox9 plays a role in influencing P53 apoptotic signaling either by directly 
modulating P53 levels or the expression of P53 ‘collateral’ signaling pathways. In 
chondrocytic CFK2 cells, SOX9 has been shown to transcriptionally regulate P53 
mRNA expression. Namely, SOX9 overexpression results in a down regulation of P53 
expression.123 Whether Sox9 represses damage induced P53 expression in the 
intestinal epithelium is unclear. However, this possibility could be explored in future 
studies by assessing the levels of P53 expression elicited in Sox9 knockout animals 
following radiation damage.  
It’s also possible that Sox9 influences P53 signaling by modulating the 
expression of ‘collateral’ signaling networks. As previously mentioned, overexpression 
of MYC in human colon cancer cell lines increases P53 dependent apoptosis.120 
Consistent with this observation, genetic ablation of Myc completely abrogates 
apoptosis following radiation damage in IECs in vivo.120 Importantly, the genetic ablation 
of Sox9 in the intestinal epithelium results in increased expression of Wnt signaling 
targets including Myc. Taken together these results indicate that Sox9 may inhibit P53 
dependent apoptosis by indirectly repressing Myc expression. If so, reducing Myc 
expression in Sox9 cKO animals may rescue the radiosensitive phenotype present in 
these animals.  
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The role of Sox9 in intestinal cancer: oncogene or tumor suppressor? 
The role of Sox9 as regulator of proliferation in cancer 
 Colorectal cancer is the second most common malignancy in the world, the third 
leading cause of cancer-related death, and the prognosis of patients diagnosed with this 
disease has not improved over the last three decades.124 These observations highlight 
the need to develop a more comprehensive understanding of the molecular 
mechanisms responsible for the initiation and progression of this disease state. In the 
works presented in this dissertation, I discuss the role that Sox9 plays in maintaining the 
small intestinal epithelium under homeostatic conditions. I provide evidence that high 
levels of Sox9 expression correlate to a slowly dividing IEC state. The notion that Sox9 
inhibits proliferation in IECs is consistent with previous reports demonstrating that the 
loss of Sox9 results in increased proliferation of crypt based IECs, decreased 
expression of Wnt signaling inhibitors, and increased Wnt signaling (recall that Wnt 
signaling drives proliferation in IECs).78,96 These observations suggest that Sox9 acts as 
a tumor suppressor gene. Paradoxically, however, Sox9 is expressed at relatively high 
levels in the majority of colorectal cancers when compared to levels found in normal 
intestinal epithelium.124,125 Why Sox9 represses proliferation in normal IECs but not 
intestinal cancers remains unknown.  
The molecular mechanisms that underlie the development and propagation of 
colorectal cancer have been partially elucidated, revealing that a common feature 
among colon cancers is that they demonstrate increased Wnt signaling. 55,124 The 
inability of Sox9 to inhibit proliferation in colon cancer cells may be due to mutation 
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derived alterations in the Wnt signaling pathway that preclude Sox9-mediated 
regulation. In the majority of colon cancers, increased Wnt signaling is attributable to 
either an inactivating mutation in APC or a mutation in β-Catenin that prevents its 
ubiquitination and subsequent degradation (Figure 1.4).126 These observations support 
the hypothesis that regulation of the Wnt signaling upstream of β-Catenin degradation is 
lost in colon cancers. The observation that Sox9 represses Wnt signaling in normal 
IECs,78 but that high levels of Sox9 are not to be sufficient to repress Wnt signaling in 
colon cancer may indicate that Sox9 normally represses Wnt signaling by targeting 
upstream elements of this pathway. This possibility could be assessed by co-
overexpression of Sox9 and a dominant negative version (nondegradable) of β-Catenin 
in IEC-18 cells, a non-transformed cell line that demonstrated decreased expression of 
Wnt signaling targets following Sox9 overexpression. If Sox9 acts downstream of β-
Catenin to inhibit Wnt signaling, then Sox9 overexpression will repress Wnt signaling in 
the presence of a nondegradable form of β-Catenin. 
 
The role of Sox9 in promoting oncogenicity 
A hallmark of cancerous cells is that they are able to continue dividing in part by 
maintaining an undifferentiated state. The observation that Sox9 is overexpressed in 
cancers derived from numerous tissues and that highest levels of Sox9 expression are 
found in the most aggressive colon cancers suggests a pro-oncogenic function for 
Sox9.124 Previous studies have shown that Sox9 is able to inhibit the expression of 
factors that drive differentiation (Cdx2 and Muc2),93 while promoting the expression of 
genes that inhibit differentiation (Bmi1) in colon cancer cell lines.127 Consistent with 
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these findings, the knockdown of Sox9 in colon cancer cells in vitro promotes 
differentiation resulting in a loss of proliferative capacity.128 Additionally, Sox9 is down 
regulated as colon cancer cell lines reach confluence and spontaneously differentiate 
due to contact inhibition.128 Continued study is necessary to gain a comprehensive 
understanding of the molecular mechanisms that Sox9 employs inhibit differentiation in 
colon cancer cell lines.  
Another hallmark of cancerous cells is that they are able to evade apoptosis. The 
works presented in Chapter 2 indicate that Sox9 plays a role in inhibiting radiation-
induced apoptosis, however, it remains unknown whether Sox9 acts specifically to 
inhibit radiation induced apoptosis or as a more global inhibitor of damage induced 
apoptosis and whether the anti-apoptotic functions of Sox9 are preserved in colon 
cancer cells. An implication of this finding is that the high levels of Sox9 present in colon 
cancer cells may be responsible for imparting a damage resistant phenotype. If so, then 
the down-regulation of Sox9 may be sufficient to sensitize colon cancer cells to 
damaging agents including: radiation, chemotherapeutics, and hypoxia. This possibility 
could be addressed by knocking Sox9 down in colon cancer cell lines and subsequently 
assessing their ability to survive damage, with the expectation that the loss of Sox9 will 
make cells more prone to undergoing damage induced apoptosis. If Sox9 does promote 
survival, Sox9 may represent a promising molecule to target prior to the administration 





Sox9 in Paneth cell differentiation 
The genetic ablation of Sox9 from the intestinal epithelium results in a loss of the 
Paneth cell lineage.92,93 While the precise mechanism in which the loss of Sox9 results 
in the loss of Paneth cells remains unknown, the data presented in Chapter 2 of this 
dissertation provide insight into the role that Sox9 plays in Paneth cell differentiation. I 
have determined that Sox9 is necessary for the production and maintenance of Paneth 
cell precursors (LRCs), but not for the maintenance of mature Paneth cells (acute Sox9 
ablation in adult intestinal epithelium did not affect Paneth cell number).  
While Sox9 ablation in mature Paneth cells did not result in a loss Paneth cell 
morphology and lysozyme expression, it remains unknown whether Sox9 maintains 
networks in Paneth cell that promote stem cell function. In future studies it would be 
possible to acutely ablate Sox9 in Paneth cells and co-culture them with ISCs in vitro to 
determine whether Sox9 is necessary for Paneth cells to enhance ISC function. 
Importantly, our lab has developed a high-throughput culturing platform that allows for 
the assessment of thousands of co-culture events to be recorded and quantified in an 







APPENDIX A: A high throughput platform for stem cell-niche co-cultures and 





Stem cells reside in “niches”, where support cells provide signaling critical for 
tissue renewal. Culture methods mimic niche conditions and support the growth of stem 
cells in vitro. However, current functional assays preclude statistically meaningful 
studies of clonal stem cells, stem cell-niche interactions, and genetic analysis of single 
cells and their organoid progeny. Here, we describe a “microraft array” (MRA) that 
facilitates high-throughput clonogenic culture and computational identification of single 
intestinal stem cells (ISCs) and niche cells co-cultures. We use MRAs to demonstrate 
that Paneth cells, a known ISC niche component, enhance organoid formation in a 
contact-dependent manner. MRAs facilitate retrieval of early enteroids for qPCR to 
correlate functional properties, such as enteroid morphology, with differences in gene 
expression. MRAs have broad applicability to assaying stem cell-niche interactions and 
organoid development, andx serve as a high-throughput culture platform to interrogate 
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Understanding how somatic stem cells self-renew and differentiate to produce 
the functional cells of their resident tissue is essential for determining the mechanisms 
underlying a broad range of issues related to human health and disease. The intestinal 
epithelium undergoes one of the most rapid rates of renewal of any mammalian tissue, 
making it an excellent model system for understanding stem cell driven physiological 
renewal. While in vivo lineage tracing remains an important technique for the analysis of 
stem cell behavior, developments in primary stem cell culture have expanded the stem 
cell biologist’s toolkit to include powerful, complementary in vitro assays. 129,130  
Lgr5high or Sox9low ISCs are capable of forming “enteroid” structures in vitro, 
demonstrating multipotency and self-renewal.52,60,94 In vivo, ISCs are closely associated 
with Paneth cells (PCs), which function as niche cells and express soluble and insoluble 
factors associated with stemness, such as Wnt and Notch ligands.16 PCs have been 
shown to increase the efficiency of enteroid formation by ISCs in vitro.16 However, these 
studies relied on the co-culture of hundreds of ISCs with hundreds of PCs, and may not 
reflect physiological normal conditions in single intestinal crypts, where much smaller 
numbers of ISCs (~15) and PCs (~8) interact.16   
  Technical limitations hinder efficient functional in vitro studies of ISC-niche 
interactions. Additionally, the field currently lacks a robust assay to study ISCs at the 
clonal level, a tool that has driven the understanding of stem cell niches in the 
hematopoietic system and mammary glands. 131,132 Array-based technologies are 
emerging as a powerful method to study the functional characteristics of single and/or 
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small numbers of stem cells in the hematopoietic system, and hold similar promise for 
epithelial tissues such as the intestine.133 In the present study, we describe a platform to 
study large numbers of single ISCs simultaneously, either at the clonal level or in the 
presence of niche cells. Microfabricated culture arrays modified for long-term 3-
dimensional culture are used to capture and functionally assay clonal ISCs and ISC-
niche cell co-cultures, effectively providing a platform for high-throughput niche 
reconstruction using primary stem and niche cells. Finally, the platform allows for 
efficient retrieval of single ISCs and developed enteroids for downstream gene 
expression analysis at different time points.  
 
Results 
Microraft arrays are adaptable to cell culture and imaging 
We hypothesized that previously described polydimethylsiloxane 
(PDMS)/polystyrene “microraft arrays” (MRAs) could be utilized to isolate and culture 
single ISCs in three-dimensional ECM (Figure A.1A-C).134 Since ISCs require several 
days to develop into enteroids, MRAs had to be amenable to media changes.16,94 To 
meet these requirements, polycarbonate cassettes, with dividers to create multiple 
media reservoirs, were bonded to MRAs (Figure A.1A,B & Figure A.2H). Cassettes 
were fabricated with two or four culture chambers (~2,500 or 5,000 microwells per 
culture chamber, respectively, Figure A.1B). Physical well addresses, stamped into 
PDMS at 5 microwell intervals, were included in the array design to allow for tracking of 
single cells and enteroids across many time points (Figure A.1C).  Tile-scanning 
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microscopy produced high-resolution images of whole MRAs for downstream analysis 
(Figure A.1F,I & Figure A.3). 
 
Microraft arrays support long-term, clonal intestinal stem cell culture 
To facilitate tracking of isolated cells in MRAs, Sox9EGFP mice were crossed to 
CAGDsRed mice, which express the DsRed fluorescent transgene ubiquitously across all 
cell and tissue types (Figure A.1D).135 Sox9EGFPlow:DsRed+ ISCs were plated in a 
single culture chamber of a two-chamber MRA, randomly seeded into microwells by 
centrifugation, and overlaid with Matrigel and ISC-supporting growth factors (Figure 
A.1E).16,136 This resulted in a random distribution of ISCs across MRAs, with microwells 
containing one, multiple, or no ISCs (Figure A.1F-H). For biocompatibility experiments, 
we utilized high efficiency ISC culture methods that drive high Wnt and Notch 
signaling.136 Tile scanning of the MRA in the dsRed wavelength immediately after 
plating and at 48hrs revealed that isolated ISCs had begun to produce primitive 
enteroids, indicative of biocompatibility (Figure A.1F-K).  
Conventional ISC cultures are capable of supporting enteroid growth for many 
weeks. ISCs were maintained up to 8 weeks in MRAs, with retention of enteroids in their 
original microwells (Figure A.1L,M). At 8 weeks, enteroids had grown into large 
structures containing many crypts (Figure A.1M). These observations demonstrate 





Post-hoc image analysis identifies microwells containing a single stem cell 
To rapidly assess the cellular contents in each of the microwells, we developed a 
computational pipeline with the following analytical goals: 1) to identify microwells 
containing ISCs, 2) exclude empty microwells, 3) exclude microwells containing debris 
or imaging artifacts, and 4) quantify the number of ISCs per microwell (Figure A.4A). To 
achieve this, we developed an image analysis computational pipeline (Figure A.4).  
Computational analysis was able to accurately identify microwells containing the 
targeted number of initial cells, especially for single ISCs (99.87%; n=2258 visually 
validated) (Figure A.4H). Due to stringency settings adapted specifically for clonal 
analysis, the percent of identified microwells was reduced for wells containing multiple 
cells, but the incidence of falsely identified microwells remained 0% for all cell numbers 
examined (Figure A.4H,I).  
 
Sox9EGFP transgenic mice facilitate high-purity isolation of Paneth cells 
 To provide proof-of-concept for stem cell niche experiments using MRAs, we 
sought to co-culture ISCs and PCs to assess clonal and PC-influenced enteroid 
formation in vitro. Previous studies have isolated PCs by FACS of CD24High:SSCHigh 
populations.16 However, CD24 is also expressed on ISCs, TAs, and enteroendocrine 
cells. 68,136-138 Since the experimental approach of MRA cultures examines events on a 
“per well” basis, it was critical to refine isolation procedures for PCs to meet purity 
requirements of clonal and microscale co-cultures and avoid artifactual results due to 
contaminating non-PC cell types. Previous characterization of the Sox9EGFP mouse 
model demonstrated that Sox9 is expressed at different levels in ISCs, progenitors, and 
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enteroendocrine cells, but that the Sox9EGFP transgene is preferentially silenced in PCs. 
We exploited this property to isolate a highly pure population of PCs by FACS exclusion 
of Sox9EGFP populations. PCs were FACS-isolated using CD24High:SSCHigh parameters, 
and the additional exclusion of all Sox9EGFP-positive cells (Figure A.5B,C). Gene 
expression analysis revealed a 2-fold increase in lysozyme expression, a 5-fold 
decrease in Lgr5 expression, and a >10-fold decrease in Chga using Sox9EGFP 
exclusion, indicating de-enrichment of ISCs and enteroendocrine cells (Figure A.6).  
PC purity was further examined by single cell qPCR on 96 Sox9EGFP-excluded 
PCs. Sox9EGFPneg:CD24High:SSCHigh cells were morphologically consistent with PCs, 
exhibiting typical granulation and large cell size (Figure A.7A). Importantly, all isolated 
cells expressed the PC-related gene Defcr-rs (Figure A.7B,C). Lgr5 was detected in 
some cells, consistent with recent reports on Lgr5 expression in a subset of PCs in vivo 
(Figure A.7C).76 Similarly, while all cells were negative for the enteroendocrine transcript 
Tac1, expression of Chga was observed in a single PC, consistent with reports of PC 
progenitors expressing this enteroendocrine marker (Figure A.7C).76 
Emerging evidence demonstrates that multiple intestinal progenitor cell 
populations are capable of dedifferentiating and functioning as ISCs in vitro and in 
vivo.75,76,139 To address the possibility that enteroids might form from early progenitors in 
the PC population, 2,810 individual PCs were examined in subsequent in vitro 
experiments. We only once observed enteroid production by a cell isolated using 
Sox9EGFPneg:CD24High:SSCHigh parameters (0.04%). Together, these data indicate that 
Sox9EGFPneg:CD24High:SSCHigh populations are genotypically and phenotypically 
consistent with mature PCs.  
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Paneth cell-ISC contact is required for increased enteroid formation in vitro 
 As previous studies have speculated that PC-secreted WNTs are responsible for 
enhancing ISC growth in vitro, ISC-PC co-culture experiments were carried out in the 
absence of exogenous WNT, to avoid “masking” the potential impact of PCs on enteroid 
formation.16,52,129 The GSK3β-inhibitor CHIR99021, a WNT agonist, was also excluded 
from co-culture experiments. To address the possibility that a PC in one microwell might 
affect the growth of an ISC in an adjacent, but separate microwell, we modeled diffusion 
dynamics of cell secreted molecules in MRAs. Diffusion between microwells was 
deemed negligible under models relying on liberal rates of diffusion and decay.  
We hypothesized that increased numbers of PCs would result in increased Wnt 
secretion and ISC growth, and examined microwells with initial contents consisting of 
any combination of 1-5 ISCs and 0-2 PCs. ISCs were isolated from Sox9EGFP or 
Lgr5EGFP mice and PCs from Sox9EGFP:CAGDsRed mice (Figure A.8A). DsRed 
fluorescence was used as a readout of ISC contamination in PC populations. Replicate 
experiments were conducted for each ISC biomarker to increase sample size per ISC-
PC combination, and data were analyzed from four total MRA experiments, consisting 
of 4,830 data points, each corresponding to an individual microwell containing any 
combination of ISCs and PCs. Surprisingly, examination of survival percentages across 
all combinations of ISCs and PCs revealed no statistically significant trends, regardless 
of whether ISCs were isolated using Sox9EGFP or Lgr5EGFP (Figure A.8B,C). To 
investigate the overall effect of PCs on enteroid survival, we next analyzed the 
percentage of enteroids formed in microwells containing any number of ISCs or any 
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number of ISCs with any number of PCs (Figure A.8D). These analyses also failed to 
produce statistically significant differences between ISC-only and ISC-PC microwells, 
suggesting that PC presence alone is insufficient to increase enteroid formation in vitro 
at physiologically relevant numbers.  
Previous studies have suggested that cell-to-cell contact between ISCs and PCs 
may influence enteroid formation, but this has not been formally tested by comparison 
between touching and non-touching ISCs and PCs.6 Using the same data generated in 
our ISC-PC co-culture experiments, we reanalyzed initial MRA contents to classify 
microwells by cell-to-cell contacts at t=0hr and correlated this status with enteroid 
formation outcome (Figure A.8E).  This comparison yielded results with overall 
statistical significance (p = 0.0282), indicating that ISCs in direct contact with PCs are 
more likely to form enteroids than ISCs alone, or ISC-PC wells that are not in direct 
contact. Interestingly, ISC-ISC contact events were also more likely to form enteroids 
than non-touching ISCs, suggesting that cell-to-cell contact between two or more ISCs 
may also positively influence enteroid formation. As expected, PC-PC contact did not 
result in the formation of enteroids, consistent with the post-mitotic status of PCs in vivo 
and the high level of purity observed in PC populations  (Figure A.8G).  
 
Single cells do not form de novo contacts after plating 
The contact-dependent effects on enteroid formation prompted us to ask if de 
novo cell-cell contacts occurred after initial classification as “non-touching” at t=0hr. To 
assay this, we measured the distance between ISC-ISC, ISC-PC, and PC-PC pairs in 
microwell images acquired at t=0hr and calculated positive or negative changes in cell-
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cell distance at t=24hr (Figure A.9). Microwells in which both cells were alive at 24hr 
were included for analysis, resulting in n = 905 pairs (521 ISC-ISC; 345 ISC-PC; 39 PC-
PC) (Figure A.9B). To control for background movement due to known changes in 
extracellular matrix integrity that occur over time, measurements were taken on pairs of 
fixed intestinal epithelial cells for comparison (n = 50). Analysis of change in distance in 
alive pairs demonstrated that: 1) cell movement was statistically significant compared to 
measurements taken on pairs of fixed cells, and 2) no observed cells formed de novo 
contacts after initial plating of MRAs. Interestingly, non-touching pairs of cells with an 
initial cell-cell distance ≤ 25µm appear to grow further apart within the first 24hrs of 
culture (Figure A.9C). Together, these data demonstrate that single cells migrate within 
Matrigel cultures and that cell-cell signaling may repel single cells from one another 
over short distances in vitro. 
Previous studies demonstrate significant enteroid movement and merger in vitro. 
To further examine cell movement in the MRA platform, we performed time-lapse 
imaging of microwells. Single cells demonstrated appreciable movement as they 
developed into enteroids over the first 24hrs of culture. Larger clumps of cells merged 
into single enteroids, suggesting that the movement and merger of ISCs in vitro may be 
influenced by cell number or heterogeneity within populations. 
 
Modified MRAs facilitate genetic analysis of enteroid development  
 Microscale culture systems for primary tissues are potentially powerful tools for 
high-throughput screening, drug discovery, and personalized medicine. The power of 
such platforms is enhanced when differences in phenotype, such as organoid size or 
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morphology, can be correlated with differences in gene expression. We reasoned that 
MRAs could be utilized to examine genetic heterogeneity in single ISCs, early enteroids 
(2-3 cell), and developed enteroids. To facilitate single ISC and enteroid retrieval for 
downstream analysis, MRAs were modified so that standard polystyrene rafts at the 
bottom of each microwell were replaced with magnetized rafts, as recently described 
(Figure A.10A).134,140 A raft release device was fitted to a 10X objective to liberate the 
rafts from the PDMS wells, and a magnetic wand was used to retrieve rafts for transfer 
to RNA lysis buffer (Figure A.10A-D). Rafts containing single Lgr5high ISCs or enteroids 
were retrieved and cDNA was generated from a total of 192 rafts, representing single 
ISCs, early enteroids, and developed enteroids, across 6 times points  (Figure A.10G, 
Figure A.11A). High-throughput qPCR was then used to assess the expression of 20 
genes associated with ISCs, progenitors, and post-mitotic lineages (Figure A.11B,C). 
Representative analysis of Sox9, Hopx, and Ccnd1 in empty rafts (n=12) produced a 
only a single Ct value for Sox9 (Ct = 36.97 of 40 cycles), but did not produce a visible 
band by gel electrophoresis, demonstrating negligible background in retrieved rafts.  
As expected, Lgr5 mRNA was highly expressed by single ISCs, demonstrating 
population purity (Figure A.11C). Though other crypt-base columnar ISC markers Olfm4 
and Smoc2 were strongly detected in single ISCs, a number of cells were negative for 
putative “+4” ISC markers Bmi1, Hopx, and Tert, contrary to studies conducted on 
populations of Lgr5high cells.61,65,67,72 To test if this finding was reflective of a 
transcriptional response to ISC culture conditions, we compared gene expression 
profiles of single Lgr5high cells sorted directly into lysis buffer with those exposed to 
Matrigel culture with and without growth factors/small molecules (EGF, Noggin, Jagged-
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1, CHIR99021, LY2157299, and Thiazovivin). While growth factors specifically elicited 
upregulation of Lgr5, Olfm4, and Lyz2 in single cells, Lgr5high ISCs exhibited 
heterogeneity in terms of Bmi1, Hopx, and Tert regardless of exposure to culture 
conditions (Figure A.12). Together, these data demonstrate that ISC culture conditions 
upregulate ISC-associated genes and Lyz2 in single cells and suggest transcriptional 
heterogeneity for Bmi1, Hopx, and Tert in Lgr5high cells. 
Gene expression changes in developing enteroids were consistent with cellular 
differentiation (Figure A.11C). Hes1 was enriched at 24hrs post-plating, suggesting 
initiation of Notch signaling, which was recently shown to be important for progenitor 
fate decisions.141 Subsequently, Dll1 expression initiates in a majority of enteroids at 48-
hours, consistent with the emergence of secretory progenitor populations. 75,142 Early 
expression of Sis appears to be coincident with upregulation Hes1, a known driver of 
enterocyte fate, while Muc2 and Chga are upregulated at later time points, coincident 
with increased Atoh1 expression. 143,144 By 10 days in culture, enteroids are enriched for 
the expression of transcripts associated with absorptive enterocytes (Sis), goblet cells 
(Muc2), PCs (Lyz, Defr-rs1), and endocrine cells (Chga, Chgb), consistent with a fully 
developed organoid phenotype (Figure A.11B,C).52 
 
MRAs reveal genetic differences associated with enteroid phenotype 
While enteroid development demonstrated an expected pattern of gene 
expression associated with differentiation, we noted bimodal distribution of several 
genes across the developmental timeline, suggesting heterogeneity in enteroid 
populations (Figure A.11C). To examine this, we chose two previously observed 
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morphologies, cystic and columnar, and collected enteroids for gene expression 
analysis at 24hr and 48hr, based on these morphologies (Figure A.11D).129 The cellular 
“monolayer” of cystic enteroids was determined to be significantly thinner than that of 
columnar enteroids, confirming the morphological difference (Figure A.11E).  Since 
cystic enteroid morphology is observed coincident with increased Wnt signaling, we 
expanded our analysis to include genes associated with Wnt and cell cycle (Figure 
A.13, Figure A.14).129 Principle components analysis revealed that enteroids were 
similar at 24hr, regardless of morphology (Figure A.11F). However, at 48hr, cystic 
enteroids exhibited dissimilar gene expression profiles relative to columnar enteroids at 
the same time point. Most notably, genes associated with cell cycle progression, Ccnb1, 
Ccnd1, and Ccne1 were upregulated in cystic enteroids relative to columnar enteroids 
at 48hr (Figure A.11G). Additionally, more cystic enteroids exhibited higher expression 
levels of ISC markers Lgr5 and Ascl2, and Wnt receptor Fzd6 at 48hr, compared to 
columnar enteroids. Together, these data suggest that cystic morphology in early 
enteroids correlates with a proliferative phenotype, and demonstrate the ability to 
dissect functional and phenotypic changes at the genetic level using the MRA platform.  
 
Discussion 
 Stem cell niches provide critical extrinsic signals that govern stem cell self-
renewal and differentiation, but their anatomical locations and complexity often present 
significant challenges to the study of stem cell-niche interactions in vivo. As an 
alternative approach, in vitro techniques that rely on the co-culture of isolated stem and 
niche cell populations have recently been used to assess the impact of individual niche 
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components on stem cell behavior.16,145 However, these methods commonly rely on 
large numbers of cells, which may not reflect physiologically relevant niche behavior, 
and are not amenable to high-throughput studies. Here, we present an array-based 
platform that facilitates the study of thousands of isolated stem and niche cells.  
PCs express soluble and insoluble ISC niche signaling components, including 
Wnt and Notch ligands.16,129 In the present study, we examine the impact of PC 
presence and contact with ISCs on enteroid formation. Interestingly, we find that PC 
presence alone is not predictive of enteroid formation. Rather, direct cell-to-cell contact 
between ISCs and PCs is required for enhanced ISC growth, suggesting that insoluble 
or very short-range soluble signals support ISCs in vitro. These results support in vivo 
findings that stemness is most strongly correlated cells that exist in intimate contact with 
PCs, and provide new insight to the functional role of PCs in maintaining stemness.16 
Importantly, the MRA platform was critical in testing dose and contact-dependency of 
PCs in a microscale format. 
 In addition to providing a robust platform for studying functional outcomes of 
clonal stem cells or stem cell-niche cultures, MRAs allow for the retrieval of single cells 
and organoids for downstream analysis. This ability enhances the power of MRAs by 
integrating high-throughput functional and genetic/genomic data. We used magnetic 
MRAs in combination with microfluidic qPCR technologies to assess gene expression in 
single cells and small populations, such as 2-3 cell enteroids. This allowed for 
observations of gene expression changes over the course of enteroid development, as 
well as proof-of-principle analysis of morphological differences in early enteroids. These 
data experimentally reinforce a previously observed correlation between cystic enteroid 
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morphology and increased Wnt signaling, by demonstrating that cystic enteroids 
express higher levels of genes associated with stemness and active proliferation.129 
Together with methodology for low-input RNA-seq, MRAs potentiate screening of 
genetic mutants and drugs/small molecules at the genomic level.146 
Array-based stem cell culture platforms are growing in use and present an 
efficient and cost-effective alternative to conventional cell culture.147,148 However, most 
platforms are not amenable to long-term cultures, such as required for the development 
of ISC-derived enteroids and other self-assembled, stem cell derived organoids.149-152 
MRAs facilitate the culture of thousands of primary stem cells over many days and 
weeks as well as high throughput reconstitution of the stem cell niche at physiologically 
relevant cell numbers. The power of the MRA platform is further highlighted by the 
ability to retrospectively “mine” existing high-throughput MRA datasets to test new 
hypotheses, such as niche cell dose-dependency, cell-cell contact, and cellular 
movement within microwells.  
MRAs provide robust methodology for screening candidate mitogens and 
morphogens for their effect on enteroid formation and development, and the study of 
other ISC niche cells, such as pericryptal myofibroblasts, endothelial cells, and neurons. 
Additionally, MRAs have broad potential for in vitro reconstruction of stem cell niches 
across a range of cell and tissue types, especially those that require three-dimensional 
ECM. The ability to easily retrieve a high replicate number of organoids early in their 
development allows investigators to associate functional observations with dynamic 
changes at the genetic and transcriptomic level, facilitating next-generation forward 
genetic screens in primary stem cells.     
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Methods  
Fabrication of glass mounted microwell arrays 
SU-8 photoresist was purchased from MicroChem Corp. (Newton, MA).  The 
Sylgard 184 silicone elastomer kit was purchased from Dow Corning (Midland, MI).  γ-
Butyrolactone (GBL), octyltrichlorosilane, and propylene glycol monomethyl ether 
acetate were obtained from Sigma-Aldrich (St Luois, MO).  Poly(acrylic acid) (MW 
~5,000) was obtained from PolySciences, Inc. (Warrington, PA).  Falcon™ Petri dishes 
were obtained from BD Biosciences (San Jose, CA).  Polycarbonate plates (12 inch × 
12 inch × 0.5 inch) were purchased from McMaster-Carr (Los Angeles, CA) and glass 
slides (75 mm × 50 mm × 1 mm) were purchased from Corning Inc. (Corning, NY). 
 
Fabrication of glass-backed PDMS microwell array. 
 An SU-8 master mold with an array of microposts was fabricated using standard 
photolithography with 100 µm thick SU-8 as described previously 1. The SU-8 master 
was coated by octyltrichlorosilane using vapor deposition to render the surface of the 
master non-sticky to PDMS 2. Clean glass slides (75 mm × 50 mm × 1 mm) were spin 
coated with a 15-µm thick layer of poly(acrylic acid) (PAA) by using 50 wt% solution and 
a spin speed of 2000 rpm, followed by a 1 hr bake on a 100°C hotplate to remove the 
water.  The slide coated in PAA was treated in a plasma cleaner for 10 min (Harrick 
Plasma, Ithaca, NY).  PDMS prepolymer (10 : 1 mixture of base : curing-agent of 
Sylgard 184 kit) was spread on the SU-8 master mold and degassed under vacuum to 
remove trapped air bubbles.  To control the thickness of the PDMS mold, 300-µm 
PDMS spacers were placed on both ends of the master mold.  PDMS spacers were 
	  82	  
created by spin-coating glass with PDMS prepolymer at 200 rpm for 30 s and cured on 
a 120°C hotplate for 30 min. The plasma-treated PAA-coated glass slide was then 
placed on the master mold, flattening the PDMS prepolymer between the master mold 
and the glass slide (supplemental material, Fig. S1A).  The ends of the master-glass 
slide assembly were secured by paper clips to prevent movement during curing of the 
PDMS.  The PDMS was cured in a 95°C oven for 1 hr (supplemental material, Fig. 
S1B).  The glass-backed PDMS microwell array was then obtained by separating the 
array from the silanized master mold (supplemental material, Fig. S1C).  The resulting 
microwell array has an array area of 25.4 mm × 25.4 mm, and each microwell has a 
dimension of 200 µm × 200 µm × 100 µm spaced 30 µm apart.  
 
Micromolding of microraft arrays by dip coating.  
A polystyrene solution was prepared by dissolving polystyrene Falcon™ Petri 
dishes in GBL at 20 wt% concentration.  The polystyrene solution was spread onto the 
PDMS microwell array and degassed under vacuum to remove trapped air bubbles 
(supplemental material, Fig. S1D).  The glass-backed PDMS array was then immersed 
in the polystyrene solution and withdrawn vertically at a speed of 0.83 mm/min by a 
stepper motor controlled by a custom controller (supplemental material, Fig. S1E). Due 
to surface tension difference between PDMS and polystyrene solution, polystyrene 
solution dewetted from the array, resulted in isolated pockets of polystyrene solution in 
microwells (supplemental material, Fig. S1F). This phenomenon is called discontinuous 
dewetting 3. The array was then placed in a 95°C oven overnight to evaporate the GBL 
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solvent, and pockets of polystyrene solution shrunk into solid polystyrene microrafts with 
a concave geometry (supplemental material, Fig. S1G). 
 
Attaching the array to the cassettes.  
The array was attached to a rigid 2-chamber or 4-chamber polycarbonate 
cassette, which was fabricated by computer numerical control (CNC) machine 
(supplemental material, Fig. S1H). Prior to attachment, the cassette was cleaned by 
sonication in a solution of 1 wt% detergent in water for 1 hr, followed by a 1 hr 
sonication in a 75% ethanol solution.  The cassette was rinsed thoroughly in DI water 
and baked for 15 min in a 95°C oven to remove any remaining solvent.  Both the array 
and the cassette were treated in plasma cleaner for 10 min before being glued together 
with PDMS (cured in a 95°C oven for 1 hr).  The arrays were treated with air plasma for 
5 min, sterilized with 75% ethanol, and stored in sterile 1X PBS prior to use. 
 
Epithelial isolation and FACS 
 Epithelial cells were isolated from whole murine intestines, as previously 
described, with some modifications 4. Briefly, intestines were opened longitudinally, 
rinsed in DPBS (Life Technologies, Grand Island, NY), minced, and incubated in 3mM 
EDTA (Sigma, St Louis, MO) in DPBS for 45min at 4°C with gentle agitation. Intestinal 
fragments were transferred to fresh DPBS and shaken by hand for 2 minutes to release 
epithelium. Remnant submucosa was discarded, epithelium was rinsed twice in DPBS, 
and then dissociated to single cells by incubation in 0.3U/mL dispase (Life 
Technologies) in 10mL HBSS (Life Technologies) at 37°C for 8-10 min with shaking 
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every 2 minutes. Single epithelial cells were filtered through 100, 70, and 40µm filters 
before being resuspended in ISC Sort/Culture Media [Advanced DMEM/F12 (Life 
Technologies), N2 (Life Technologies), B27 (Life Technologies), Glutamax (Life 
Technologies), Penicillin/Streptomycin (Life Technologies), 10mM HEPES (Life 
Technologies), 10µM Y27632 (Selleck Chemicals, Houston, TX), and 500mM N-acetyl-
cysteine (Sigma)]. For Paneth cell isolation, cells were resuspended in ISC Sort/Culture 
Media with 5% FBS (Gemini Biosciences) and stained with the following antibodies: 
Brilliant Violet conjugated anti-CD24 (clone M1/69, Biolegend, San Diego, CA); PerCP-
Cy5.5 conjugated anti-CD45 (clone 30-F11, Biolegend). All cells were stained with 
Sytox Blue (Life Technologies) or 7-AAD (Biolegend) and Annexin V-APC (Life 
Technologies) prior to FACS, for live-dead exclusion.  
 FACS was conducted on a MoFloXDP (Beckman Coulter, Pasadena, CA) and 
Sox9EGFP and Lgr5EGFP cells were isolated as previously described 4-6. Paneth cells 
were isolated by high expression of CD24, high side-scatter (SSC), and exclusion of 
CD45, with or without exclusion of Sox9EGFP (supplemental material, Fig. S3A&C). Cells 
were collected into ISC Sort/Culture Media for array culture and RNaqueous lysis buffer 
for qPCR analysis (Ambion RNaqueous Micro Kit, Life Technologies).  
 
Single cell isolation and qPCR 
For single Paneth cell gene expression analysis, Paneth cells were sorted as 
described earlier and applied to a 10-17µm C1 Autoprep microfluidics chip (Fluidigm, 
San Francisco, CA) to generate a targeted cDNA library.  Specific targets were pre-
amplified using the following Taqman (Life Technologies) probe sets against genes of 
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interest (supplemental material, Table S2). All other operations were conducted 
according to manufactures protocols. The specific target amplified (STA) libraries were 
applied to the Biomark HD microfluidics chip (Fluidigm) to conduct qPCR. The same 
probes sets used for the STA were used in the Biomark HD to detect relative gene 
expression levels.  Binary gene expression (on/off) was calculated by differentially 
summing the number of cells with a positive Ct value or negative Ct value. The ratio of 
expressing vs. non-expressing cells was calculated by using 96 single cells as the 
denominator for all genes assessed. Data were analyzed and heat maps were 
generated using the Fluidigm Real-Time PCR analysis software and delta-Ct values 
were calculated using the GAPDH Ct for normalization. 
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